Pages
- About Anju
- Act Hybrid Clinical Trials Webinar
- Anju eClinical Webinar: Optimizing Clinical Trials - A Comprehensive Approach
- Anju eClinical Webinar: Optimizing Clinical Trials - A Comprehensive Approach
- Anju eClinical Webinar: Optimizing Clinical Trials - A Comprehensive Approach
- Anju Medical Affairs Webinar: Accelerate Your Publication Approval Process with Pubstrat MAX Video
- Anju Medical Affairs Webinar: Pubstrat MAX 9.2 Release Review
- Anju: Empowering Life Sciences with Smart Innovation
- Blog
- California Privacy Rights/Policy
- Careers
- Automation Engineer (Pune, India)
- Customer Success Manager (Remote, US)
- Data Analyst (Pune, India)
- Data Analyst (Pune, India)
- DevOps Specialist (Pune, India)
- Director IT Systems (Ft Lauderdale, FL)
- Director of Business Development
- Director of Business Development (Belgium or Germany)
- Director of Business Development (Chicago, IL)
- Director of Business Development (NE Region, US)
- Director of Business Development (Remote, Mid Atlantic US)
- Director of Business Development Houston TX
- Manager, Quality & Compliance, Audits (Eastern US/Midwest US Remote)
- Product Manager eClinical (Remote, US)
- Project Manager (Remote, UK or Germany)
- Project Manager, PMO (Pune or Bangalore, India)
- Project Manager, PMO (Remote, US)
- Quality Assurance Manager (Pune, India)
- Senior Automation Engineer (Pune, India)
- Senior Quality Assurance Analyst (Bangalore, India)
- Senior Quality Assurance Analyst (Pune/Bangalore, India)
- Senior Software Developer (Bangalore, India)
- Senior Software Engineer (Bangalore, India)
- Senior Technical Support Engineer (Pune, India)
- Senior Technical Support Engineer (Remote, US)
- Sr. Quality & Compliance Specialist (Remote, US)
- Technical Support Engineer (Remote, US)
- Technical Support Representative (Bangalore, India)
- Technical Writer (Pune, India)
- Company
- Contact Support
- Data Protection
- Data Science
- Data Science Services
- Dia 2021 Global Annual Meeting Decentralized Trials Presentation
- DIA Med Info Europe: Pre and Current COVID Medical Information Call Center World
- Download the Use Case: TA Scan Trial Planning
- eClinical
- eClinical Services
- Events
- iCare MAX Webinar: Instant Access to Medical Information
- Inquiries & Locations
- Insights
- Instant Access to Medical Information: Anju's Self-Service Portal iCare MAX Webinar Replay
- Instant Access to Medical Information: Webinar Replay
- IRMS MAX
- IRMS MAX Medical Information Solution
- ISMPP EU 2022
- KOL Identification Webinar
- Management
- MedExpert MAX
- Medical Affairs
- Medical Affairs Services
- Medical Affairs Webinar: Accelerate Your Publication Approval Process with Pubstrat MAX Replay Video
- Newsletter Subscription
- Organizer Dashboard
- Partner Program
- Pharma Europe 2021 Presentation KOL Data TA Scan
- Post an Event
- Press Releases
- Privacy Policy
- Project Manager (Remote US)
- Pubstrat MAX 9.2 Release Review Webinar Replay
- Request A Demo
- Schedule a TA Scan Demo
- Services
- Sitemap
- Solutions
- Submit Organizer Form
- Submit Venue Form
- TA Scan
- TA Scan
- TA Scan -Essential
- TA Scan CRM
- TA Scan Limitation of Liability
- Technology
- TrialMaster
- TrialMaster: The Right EDC Solution For Oncology Trials
- Utilizing Adaptive Systems to Get the Most from Decentralized Trials
- Utilizing Adaptive Technology Systems to Get the Most from Decentralized Trials Watch Presentation Now!
- Venue Dashboard
- Webinar Ai In Medical Affairs
- Webinar Replay: Accelerate Publication Approval Process
- Webinar Replay: Breaking Barriers: Meeting Diversity Goals in Clinical Trials through Innovative Smart Trial Design Strategies Video
- Webinar Replay: Innovative Strategies in Clinical Trials
- Webinar Replay: Pubstrat MAX 9.2 Release Review
- Webinar Replay: Tackling the Challenges of Complex Trials
- Webinar: Accelerate Your Publication Approval Process with Pubstrat MAX
- Webinar: Online Collaboration with Pubstrat MAX
- Webinar: Online Collaboration with Pubstrat MAX Video
- Webinar: Optimizing Clinical Trials - A Comprehensive Video
- Webinar: TA Scan - Differentiating RFPs
- Webinar: TA Scan – Differentiating RFPs Video
- Webinar: Tackling the Challenges of Complex Trials
- Webinar: Tackling the Challenges of Complex Trials Replay Video
Posts
All News
- 10 Global Medical Affairs Conferences to Attend in 2020
- 10 Medical Affairs Conferences in Late 2020 and Early 2021
- 17th Annual Meeting of ISMPP 2021
- 2019 European Meeting of ISMPP
- 2020 Conferences for CROs and Clinical Trial Professionals
- 2020 European Meeting of ISMPP: Achieving Clarity, Reach and Value
- 6th European Clinical Research Conference: Presentations
- Anju at DIA 2021 Global Annual Meeting
- Anju at DIA China: Utilizing Clinical Trial Technology
- Anju Discusses COVID Impact on Call Center at DIA
- Anju Innovation Forum Day 1 Highlights
- Anju Leads Virtual Medical Content Compliance at TIPPA
- Anju Proudly Sponsors DIA MASC 2021 Forum
- Anju Showcases TA Scan at SCOPE Europe 2018
- Building Opinion Leader Relationships in a Post-Pandemic World
- Can’t Miss Sessions at ACDM22
- CBI Medical Publications & Communications Forum – Anju
- ClinChoice & Anju Partner: Life Science Information Management
- Come visit us at the TIPPA Conference in San Diego
- DIA 12th Annual European Medical Information Conference
- DIA 2023 Global Annual Meeting: Can’t-Miss Sessions
- DIA Global Trial Disclosure & Data Conference
- DIA Medical Information and Communications Conference
- DMB Conference in Paris This November: Celebrating 25 Years
- How Big Data and AI Are Changing the Role of Medical Affairs
- How Patient Voices Power Pharmaceutical Innovation
- Insights from DIA 2019 Global Annual Meeting
- ISMPP EU Virtual Conference 2021
- ISMPP West 2019: Changing Tides in Scientific Communications
- ISMPP West 2021: Opportunities for Connectivity
- Join Anju at OCT Europe for Best Practices in Utilizing Decentralized Trials Technology
- Join Anju at OCT West Coast: Decentralized Trials
- Join Anju at Pharma Europe 2021: MSL Empowerment Talk
- Join ISMPP in Sunny San Diego for Historic Meeting
- MAPS Annual Meeting 2019 – Not just a one-time event…
- MASS West 2019 – Medical Affairs Strategic Summit
- Meet Anju’s Data Division at Eyeforpharma Philadelphia 2019
- Meet Anju’s Data Divison at Eyeforpharma Barcelona 2019
- Meet Us at 15th Annual ISMPP Meeting, National Harbor
- Merck Technology Symposium 2019
- Message to Clients – COVID-19
- Notable Speakers: DIA Medical Information Conference
- OCT Europe 2022: A Preview
- Our Most Anticipated Events at DIA MASC 2023
- Rare Disease Clinical Trials: Challenges and Opportunities Researchers Face
- SCOPE Europe 2022: Don’t Miss These Events
- SCOPE Summit 2020: Anju’s eClinical Solutions
- The 66th Yaku-Kon Seminar in Ghent, Belgium
- There is no other event like DIA 2019 Global Annual Meeting
- Top Events and Speakers at the DIA 2022 Global Annual Meeting
- Visit TA Scan and Zephyr at SCOPE Europe 2019
- Visit TA Scan, Zephyr and ClinPlus at SCOPE Summit 2019
- Visit us at The PharmaSUG 2019: June 16-19 in Philadelphia
- What to Expect at OCT Europe
Case Study
Clinical Trial Design
- A Global Approach: Clinical Trials in Emerging Markets
- AI and ML in Clinical Data Management
- Data Analysis on Latest Clinical Research for Parkinson’s Day
- Data Analysis on Research for Multiple Sclerosis Day
- Data Interoperability and Sharing: Practical Considerations
- Diverse Clinical Trials: A Necessity for Personalized Medicine
- Experimental Design: New Therapies Are Being Developed to Treat Lifelong Illness
- Geriatric Research: Why Your Study Should Include More Seniors
- How To Prevent Systemic Bias in Clinical Trials
- Laurence Birch Interview: Adaptive Life Sciences Tech
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
- The Importance of Diversity in Clinical Trials: A Comprehensive Analysis
- The Role of Site Selection in Promoting Health Equity
- Understanding Cross-Border Enrollment for International Clinical Trials
- Why Time Management is Essential for Clinical Trials
- Women’s Representation in Clinical Trials: Beyond Equality
- Working With Disparate Data Sources To Improve Your Trials
Clinical Trial Design
- A Global Approach: Clinical Trials in Emerging Markets
- AI and ML in Clinical Data Management
- Data Analysis on Latest Clinical Research for Parkinson’s Day
- Data Analysis on Research for Multiple Sclerosis Day
- Data Interoperability and Sharing: Practical Considerations
- Diverse Clinical Trials: A Necessity for Personalized Medicine
- Experimental Design: New Therapies Are Being Developed to Treat Lifelong Illness
- Geriatric Research: Why Your Study Should Include More Seniors
- How To Prevent Systemic Bias in Clinical Trials
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Rare Disease Clinical Trials: Challenges and Opportunities Researchers Face
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
- The 66th Yaku-Kon Seminar in Ghent, Belgium
- The Importance of Diversity in Clinical Trials: A Comprehensive Analysis
- The Role of Site Selection in Promoting Health Equity
- Understanding Cross-Border Enrollment for International Clinical Trials
- Visit TA Scan, Zephyr and ClinPlus at SCOPE Summit 2019
- Why Time Management is Essential for Clinical Trials
- Women’s Representation in Clinical Trials: Beyond Equality
- Working With Disparate Data Sources To Improve Your Trials
CTMS
- Accurate Clinical Trial Forecasting and Budgeting Strategies
- How CTM Software Can Improve Site Selection For Clinical Trials
- How to Achieve CTMS Best Practices: Train Your Staff
- How to Simplify the Clinical Trial Regulatory Submission Process
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Resolving Patient Reimbursement Challenges in Clinical Trials
- SCOPE 2023 Conference Preview
- What to Consider When Adopting New Technology in Clinical Trials
Data Privacy
Data Science
- 3 Tips to Perform a Disease Landscaping Analysis
- A Global Approach: Clinical Trials in Emerging Markets
- Achieving Transparency: Why and How to Share Trial Results Data
- AI and ML in Clinical Data Management
- Analysis performed by Anju via TA Scan on COVID-19
- Anju Expands Clinical Research Data Site & Investigator Optimization Offering
- Anju Expands ta-Scan Offering
- Anju to Exhibit and Present at EUCROF24: Leveraging Data for Enhanced Site Selection and Feasibility in Clinical Trials
- Anju’s TA Scan Analysis of COVID-19 Update
- Anju’s TA Scan Selected by Leading Pharma Company to Enhance Clinical Research
- Automation, Analytics, AI and the Future of Trial Monitoring
- Breaking Down Data Silos in Life Sciences
- Building Opinion Leader Relationships in a Post-Pandemic World
- Chronic Obstructive Pulmonary Disease: Latest Clinical Data
- Clinical Data Analysis: 3 Most Important Frontiers Right Now
- Community Pharmacies and Clinical Trial Enrollment
- COVID-19’s Impact on Data Collection in Trials
- Data Analysis on Latest Clinical Research for Parkinson’s Day
- Data Analysis on Research for Multiple Sclerosis Day
- Data Interoperability and Sharing: Practical Considerations
- Diverse Clinical Trials: A Necessity for Personalized Medicine
- Do You Have a Selection Strategy for Your Clinical Trial Endpoints?
- Experimental Design: New Therapies Are Being Developed to Treat Lifelong Illness
- Geriatric Research: Why Your Study Should Include More Seniors
- Global Diversity Data with TA Scan at SCOPE Europe 2023
- How Do We Solve Pharma’s Data Dysfunction Conundrum?
- How Historical Data and Controls Improve Clinical Trials
- How Patient-Centricity is Becoming a Cliche and The Crucial Tool in Anju’s Arsenal
- How the Right Software Can Help Small Biopharma Companies Succeed
- How To Prevent Systemic Bias in Clinical Trials
- How Trial Managers Can Increase Diversity in Clinical Trials
- Human Analysis Crucial in AI-Driven Data Management
- Improve MA Decision-Making With Advanced Business Intelligence Tools
- Informed Site Selection is Mission Critical in Post COVID-19 Era
- Insights into the 2023 ASCO Annual Meeting
- International Research Collaboration: What Tools Can Help
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Maximize Product Launch Success with Connected Clinical and Commercial Strategies
- Meeting KOLs via Data Makes Initial Communications More Meaningful, Builds Relationships
- Optimizing Clinical Trial Outcomes Through Predictive Enrollment Strategies
- Overcoming Data Management Challenges in Self-Reporting Clinical Trials
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
- The Benefits of Big Data in Drug Development
- The Importance of Diversity in Clinical Trials: A Comprehensive Analysis
- The Present and Future of Synthetic Data
- The Role of Site Selection in Promoting Health Equity
- Trial Eligibility Criteria: The Problem with Current Exclusion Strategies
- Understanding Cross-Border Enrollment for International Clinical Trials
- Understanding the Value of Blockchain for Clinical Trial Data
- Using AI to Formulate Clinical Trial Research Questions
- Why Time Management is Essential for Clinical Trials
- Women’s Representation in Clinical Trials: Beyond Equality
- Working With Disparate Data Sources To Improve Your Trials
Data Science
- 3 Tips to Perform a Disease Landscaping Analysis
- A Global Approach: Clinical Trials in Emerging Markets
- Achieving Transparency: Why and How to Share Trial Results Data
- Adaptive Data Analysis Changing World – Anju
- AI & Machine Learning in Clinical Data Management
- AI and ML in Clinical Data Management
- Analysis performed by Anju via TA Scan on COVID-19
- Anju’s TA Scan Analysis of COVID-19 Update
- Anju’s TA Scan Selected by Leading Pharma Company to Enhance Clinical Research
- Automation, Analytics, AI and the Future of Trial Monitoring
- Breaking Down Data Silos in Life Sciences
- Building Opinion Leader Relationships in a Post-Pandemic World
- Chronic Obstructive Pulmonary Disease: Latest Clinical Data
- Clinical Data Analysis: 3 Most Important Frontiers Right Now
- Community Pharmacies and Clinical Trial Enrollment
- COVID-19’s Impact on Data Collection in Trials
- Data Analysis on Latest Clinical Research for Parkinson’s Day
- Data Analysis on Research for Multiple Sclerosis Day
- Data Interoperability and Sharing: Practical Considerations
- Diverse Clinical Trials: A Necessity for Personalized Medicine
- Do You Have a Selection Strategy for Your Clinical Trial Endpoints?
- Experimental Design: New Therapies Are Being Developed to Treat Lifelong Illness
- Geriatric Research: Why Your Study Should Include More Seniors
- How Do We Solve Pharma’s Data Dysfunction Conundrum?
- How Historical Data and Controls Improve Clinical Trials
- How Patient-Centricity is Becoming a Cliche and The Crucial Tool in Anju’s Arsenal
- How the Right Software Can Help Small Biopharma Companies Succeed
- How To Prevent Systemic Bias in Clinical Trials
- How Trial Managers Can Increase Diversity in Clinical Trials
- Human Analysis Crucial in AI-Driven Data Management
- Improve MA Decision-Making With Advanced Business Intelligence Tools
- Informed Site Selection is Mission Critical in Post COVID-19 Era
- Insights into the 2023 ASCO Annual Meeting
- International Research Collaboration: What Tools Can Help
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Maximize Product Launch Success with Connected Clinical and Commercial Strategies
- Meeting KOLs via Data Makes Initial Communications More Meaningful, Builds Relationships
- Optimizing Clinical Trial Outcomes Through Predictive Enrollment Strategies
- Overcoming Data Management Challenges in Self-Reporting Clinical Trials
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
- The Benefits of Big Data in Drug Development
- The Importance of Diversity in Clinical Trials: A Comprehensive Analysis
- The Present and Future of Synthetic Data
- The Role of Site Selection in Promoting Health Equity
- Trial Eligibility Criteria: The Problem with Current Exclusion Strategies
- Understanding Cross-Border Enrollment for International Clinical Trials
- Understanding the Value of Blockchain for Clinical Trial Data
- Using AI to Formulate Clinical Trial Research Questions
- Why Time Management is Essential for Clinical Trials
- Women’s Representation in Clinical Trials: Beyond Equality
- Working With Disparate Data Sources To Improve Your Trials
Data Science
- 3 Tips to Perform a Disease Landscaping Analysis
- A Global Approach: Clinical Trials in Emerging Markets
- Achieving Transparency: Why and How to Share Trial Results Data
- AI and ML in Clinical Data Management
- Analysis performed by Anju via TA Scan on COVID-19
- Anju Showcases TA Scan at SCOPE Europe 2018
- Anju’s TA Scan Analysis of COVID-19 Update
- Anju’s TA Scan Selected by Leading Pharma Company to Enhance Clinical Research
- Automation, Analytics, AI and the Future of Trial Monitoring
- Breaking Down Data Silos in Life Sciences
- Building Opinion Leader Relationships in a Post-Pandemic World
- Can’t Miss Sessions at ACDM22
- Chronic Obstructive Pulmonary Disease: Latest Clinical Data
- Clinical Data Analysis: 3 Most Important Frontiers Right Now
- Community Pharmacies and Clinical Trial Enrollment
- COVID-19’s Impact on Data Collection in Trials
- Data Analysis on Latest Clinical Research for Parkinson’s Day
- Data Analysis on Research for Multiple Sclerosis Day
- Data Interoperability and Sharing: Practical Considerations
- Diverse Clinical Trials: A Necessity for Personalized Medicine
- Do You Have a Selection Strategy for Your Clinical Trial Endpoints?
- Experimental Design: New Therapies Are Being Developed to Treat Lifelong Illness
- Geriatric Research: Why Your Study Should Include More Seniors
- How Do We Solve Pharma’s Data Dysfunction Conundrum?
- How Historical Data and Controls Improve Clinical Trials
- How Patient-Centricity is Becoming a Cliche and The Crucial Tool in Anju’s Arsenal
- How the Right Software Can Help Small Biopharma Companies Succeed
- How To Prevent Systemic Bias in Clinical Trials
- How Trial Managers Can Increase Diversity in Clinical Trials
- Human Analysis Crucial in AI-Driven Data Management
- Improve MA Decision-Making With Advanced Business Intelligence Tools
- Informed Site Selection is Mission Critical in Post COVID-19 Era
- Insights into the 2023 ASCO Annual Meeting
- International Research Collaboration: What Tools Can Help
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Maximize Product Launch Success with Connected Clinical and Commercial Strategies
- Meeting KOLs via Data Makes Initial Communications More Meaningful, Builds Relationships
- Optimizing Clinical Trial Outcomes Through Predictive Enrollment Strategies
- Overcoming Data Management Challenges in Self-Reporting Clinical Trials
- Rare Disease Clinical Trials: Challenges and Opportunities Researchers Face
- SCOPE Europe 2022: Don’t Miss These Events
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
- The 66th Yaku-Kon Seminar in Ghent, Belgium
- The Benefits of Big Data in Drug Development
- The Importance of Diversity in Clinical Trials: A Comprehensive Analysis
- The Present and Future of Synthetic Data
- The Role of Site Selection in Promoting Health Equity
- Trial Eligibility Criteria: The Problem with Current Exclusion Strategies
- Understanding Cross-Border Enrollment for International Clinical Trials
- Understanding the Value of Blockchain for Clinical Trial Data
- Using AI to Formulate Clinical Trial Research Questions
- Visit TA Scan and Zephyr at SCOPE Europe 2019
- Visit TA Scan, Zephyr and ClinPlus at SCOPE Summit 2019
- Why Time Management is Essential for Clinical Trials
- Women’s Representation in Clinical Trials: Beyond Equality
- Working With Disparate Data Sources To Improve Your Trials
Data Science
- 3 Tips to Perform a Disease Landscaping Analysis
- A Global Approach: Clinical Trials in Emerging Markets
- Achieving Transparency: Why and How to Share Trial Results Data
- AI and ML in Clinical Data Management
- Analysis performed by Anju via TA Scan on COVID-19
- Anju’s TA Scan Analysis of COVID-19 Update
- Anju’s TA Scan Selected by Leading Pharma Company to Enhance Clinical Research
- Automation, Analytics, AI and the Future of Trial Monitoring
- Breaking Down Data Silos in Life Sciences
- Building Opinion Leader Relationships in a Post-Pandemic World
- Chronic Obstructive Pulmonary Disease: Latest Clinical Data
- Clinical Data Analysis: 3 Most Important Frontiers Right Now
- Community Pharmacies and Clinical Trial Enrollment
- COVID-19’s Impact on Data Collection in Trials
- Data Analysis on Latest Clinical Research for Parkinson’s Day
- Data Analysis on Research for Multiple Sclerosis Day
- Data Interoperability and Sharing: Practical Considerations
- Diverse Clinical Trials: A Necessity for Personalized Medicine
- Do You Have a Selection Strategy for Your Clinical Trial Endpoints?
- Experimental Design: New Therapies Are Being Developed to Treat Lifelong Illness
- Geriatric Research: Why Your Study Should Include More Seniors
- How Do We Solve Pharma’s Data Dysfunction Conundrum?
- How Historical Data and Controls Improve Clinical Trials
- How Patient-Centricity is Becoming a Cliche and The Crucial Tool in Anju’s Arsenal
- How the Right Software Can Help Small Biopharma Companies Succeed
- How To Prevent Systemic Bias in Clinical Trials
- How Trial Managers Can Increase Diversity in Clinical Trials
- Human Analysis Crucial in AI-Driven Data Management
- Improve MA Decision-Making With Advanced Business Intelligence Tools
- Informed Site Selection is Mission Critical in Post COVID-19 Era
- Insights into the 2023 ASCO Annual Meeting
- International Research Collaboration: What Tools Can Help
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Maximize Product Launch Success with Connected Clinical and Commercial Strategies
- Meeting KOLs via Data Makes Initial Communications More Meaningful, Builds Relationships
- Optimizing Clinical Trial Outcomes Through Predictive Enrollment Strategies
- Overcoming Data Management Challenges in Self-Reporting Clinical Trials
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
- The Benefits of Big Data in Drug Development
- The Importance of Diversity in Clinical Trials: A Comprehensive Analysis
- The Present and Future of Synthetic Data
- The Role of Site Selection in Promoting Health Equity
- Trial Eligibility Criteria: The Problem with Current Exclusion Strategies
- Understanding Cross-Border Enrollment for International Clinical Trials
- Understanding the Value of Blockchain for Clinical Trial Data
- Using AI to Formulate Clinical Trial Research Questions
- Why Time Management is Essential for Clinical Trials
- Women’s Representation in Clinical Trials: Beyond Equality
- Working With Disparate Data Sources To Improve Your Trials
Decentralized Trials
- Anju Launches New CRO Partner Program
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Avoiding 5 Pitfalls in Clinical Trial Design
- Changing Stakeholder Relationships in Clinical Trials
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Enhancing EHR Use for Efficient Clinical Trials
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- Improve Clinical Trial Management with Automated CTMS Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Insights on Using Synthetic Data for Clinical Trial Leaders
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Maximizing Decentralized Trials with Adaptive Systems
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Patient Privacy and Cybersecurity in Remote Trials
- The Continuing Rise of Decentralized Clinical Trials
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Role of Electronic Data Capture in Decentralized Trials
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why CRO Staff Need Robust Digital Literacy Skills
Decentralized Trials
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Avoiding 5 Pitfalls in Clinical Trial Design
- Changing Stakeholder Relationships in Clinical Trials
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Enhancing EHR Use for Efficient Clinical Trials
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- Improve Clinical Trial Management with Automated CTMS Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Insights on Using Synthetic Data for Clinical Trial Leaders
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Maximizing Decentralized Trials with Adaptive Systems
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Patient Privacy and Cybersecurity in Remote Trials
- The Continuing Rise of Decentralized Clinical Trials
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Role of Electronic Data Capture in Decentralized Trials
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why CRO Staff Need Robust Digital Literacy Skills
Decentralized Trials
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Avoiding 5 Pitfalls in Clinical Trial Design
- Changing Stakeholder Relationships in Clinical Trials
- ClinChoice & Anju Partner: Life Science Information Management
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Enhancing EHR Use for Efficient Clinical Trials
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- Improve Clinical Trial Management with Automated CTMS Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Insights on Using Synthetic Data for Clinical Trial Leaders
- Join Anju at OCT Europe for Best Practices in Utilizing Decentralized Trials Technology
- Join Anju at OCT West Coast: Decentralized Trials
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Maximizing Decentralized Trials with Adaptive Systems
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Patient Privacy and Cybersecurity in Remote Trials
- The Continuing Rise of Decentralized Clinical Trials
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Role of Electronic Data Capture in Decentralized Trials
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why CRO Staff Need Robust Digital Literacy Skills
Decentralized Trials
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Avoiding 5 Pitfalls in Clinical Trial Design
- Changing Stakeholder Relationships in Clinical Trials
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Enhancing EHR Use for Efficient Clinical Trials
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- Improve Clinical Trial Management with Automated CTMS Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Insights on Using Synthetic Data for Clinical Trial Leaders
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Maximizing Decentralized Trials with Adaptive Systems
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Patient Privacy and Cybersecurity in Remote Trials
- The Continuing Rise of Decentralized Clinical Trials
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Role of Electronic Data Capture in Decentralized Trials
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why CRO Staff Need Robust Digital Literacy Skills
eClinical
- 10 Reasons Why We Must Integrate EMR and EDC
- 21st Century Cures Act and Informed Consent in Trials
- 4 Lessons CROs Can Take Away From the COVID-19 Vaccine Trials
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- 5 Ways to Improve the Security of Clinical Trial Data
- 6th European Clinical Research Conference: Presentations
- Accurate Clinical Trial Forecasting and Budgeting Strategies
- Adaptations of Contract Research Organizations in Virtual Trials
- Anju at DIA 2021 Global Annual Meeting
- Anju at DIA China: Utilizing Clinical Trial Technology
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Attracting and Developing Clinical Research Associates
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Avoiding 5 Pitfalls in Clinical Trial Design
- Benefits and Challenges in Virtual Clinical Trials
- Best Practices for Managing Phase Transition in Adaptive Trials
- Bias in Clinical Trial Incentives
- Changing Stakeholder Relationships in Clinical Trials
- ClinChoice & Anju Partner: Life Science Information Management
- Clinical Research as Care Option for Better Outcomes
- Clinical Trial Costs Keep Rising: How to Fight Back
- Clinical Trial Data Privacy: What Trial Managers Need to Know
- Clinical Trial Under-Enrollment: How to Prevent It
- Collaborating With Key Opinion Leaders in Early Clinical Trial Development: Navigating Risks and Rewards
- Configurability and Customization: Key Features in an eTMF Solution
- COVID-19 Vaccine Development Enables CROs to Optimize Processes
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- CROs’ Guide to Data Protection Officers in Clinical Trials
- Current Event Analysis: Brexit, Clinical Trials and Regulations
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Designing Patient-Friendly Trials for Site Performance
- DIA Global Trial Disclosure & Data Conference
- Discussing Clinical Trial Performance Metrics with Stakeholders
- DMB Conference in Paris This November: Celebrating 25 Years
- Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
- Does Your Clinical Trial Need a Chief Patient Experience Officer?
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Ease of Implementation and Customization Spell eTMF Success
- Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop
- Enhancing EHR Use for Efficient Clinical Trials
- Enhancing Trial Planning with Screening and Randomization
- Enhancing Virtual Bedside Manner in Clinical Trials
- eTMF for ALCOA-C Compliance in Clinical Trials
- Evolution of Clinical Trials: Faster Than Ever
- Evolving Needs for CROs: Understanding FDA Expectations
- Expert Hire: Profiles of 5 Top Clinical Research Recruitment Agencies
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- FDA Guidance on Umbrella Trials Can Help CROs Choose the Best Software
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- Getting the Most Out of Your EDC Software
- Global Clinical Trials: Managing Patients and Meeting Compliance
- Global Oncology Community Leveraging Technology for Clinical Trials
- Healthcare Cyberattacks and Clinical Data Management
- How a Real-Time eTMF Dashboard Helps Keep a Trial on Track
- How AI and Machine Learning Are Reshaping Clinical Trials
- How Clinical Trial Organizations Can Convey Trust and Credibility
- How CROs Benefit from Continual Improvement Analysis and Benchmarking
- How CTM Software Can Improve Site Selection For Clinical Trials
- How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How More Data Can Lead to Shorter Clinical Trials
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How the Right Tools Make Clinical Data Integration Seamless
- How Third Party Data Can Improve Clinical Trials
- How to Achieve CTMS Best Practices: Train Your Staff
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- How to Create Social Media Content to Engage Clinical Trials Patients
- How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them
- How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
- How to Improve Patient Retention in Clinical Trials
- How To Improve the Process of Adverse Event Reporting
- How to Improve Trial Site Relationships for More Efficient Trials
- How to Manage Patient Fear Regarding Clinical Trial Risks
- How to Prepare a Successful NDA Submission
- How to Simplify the Clinical Trial Regulatory Submission Process
- How to Use Clinical Oversight Solutions Effectively
- How Will COVID-19 Impact Clinical Trials in the Long Term?
- Improve Clinical Trial Management with Automated CTMS Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Insights from DIA 2019 Global Annual Meeting
- Insights on Using Synthetic Data for Clinical Trial Leaders
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Join Anju at OCT Europe for Best Practices in Utilizing Decentralized Trials Technology
- Join Anju at OCT West Coast: Decentralized Trials
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- Lightening the Load: Reducing Patient Burden in Clinical Trials
- Managing Multiple Sources within the Clinical Data Ecosystem
- Maximizing Decentralized Trials with Adaptive Systems
- Mental Health Clinical Trials: Controversies, Challenges, Solutions
- Message to Clients – COVID-19
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- OCT Europe 2022: A Preview
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Outsourcing Data Management in 2024: Challenges and Benefits
- Overcoming Accessibility Challenges in International Clinical Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Partnering with Patient Advocacy Groups Benefits Pharma and Patients
- Patient Privacy and Cybersecurity in Remote Trials
- Patient-Centric Approach in Clinical Trial Design: Involve Patients Early
- Patient-Centric Clinical Trials: Leveraging Technology for Enhanced Participant Engagement
- Patients as Partners: The Value of Post-Trial Communication
- Precision Medicine: Its Impact on Clinical Trials and Orphan Drugs
- Price Check: How to Cut Costs in Clinical Trials
- Project Management Framework and Tools in Clinical Trials
- Rare Disease Clinical Trials: How to Improve Participation and Outcomes
- Research During a Pandemic: Trial Leadership Supporting Their Teams
- Resolving Patient Reimbursement Challenges in Clinical Trials
- Retaining Trial Participants: Adherence and Dropout Mitigation
- SCOPE 2023 Conference Preview
- SCOPE Summit 2020: Anju’s eClinical Solutions
- Social Media for Clinical Trial Recruitment
- Support for Awareness Campaigns: Good for Pharma and Patients
- Tech Skills and Digital Natives in Demand as Clinical Trial Industry Evolves
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Continuing Rise of Decentralized Clinical Trials
- The FDA Race and Ethnicity Diversity Plan: How to Get Researchers Prepared
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Importance of User Experience in Life Sciences Software
- The Regulations Clinical Researchers Should Track in 2024
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- The Role of Nurse Navigators in Oncology Trials
- The State of Clinical Research During the COVID-19 Pandemic
- The Ugly Truth About Paper Diaries
- There is no other event like DIA 2019 Global Annual Meeting
- Three Ways Decentralized Trials Bolster Patient Recruitment
- Time for Clinical Trials to Deliver on Patient-Centric Care Promises
- Top Events and Speakers at the DIA 2022 Global Annual Meeting
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Attrition: Gleaning Insights From Patients Who Quit
- Understanding FDA 483: How To Run a Compliant Trial Every Time
- Understanding HHS’ Proposed Rule Changes to HIPAA
- Understanding Risk-Based Clinical Quality Management Technology
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding Security and Role-Based Access in an eTMF Platform
- Understanding the Changing Face of Early Phase Clinical Trials
- Updated FDA Race and Diversity Guidance Open for Comments
- Video Interview: Advancing Clinical Trials with Advanced Technology
- Virtual Reality in Clinical Research: Potential and Challenges
- Visit us at The PharmaSUG 2019: June 16-19 in Philadelphia
- Voice Tech and Wearables’ Emerging Role in Clinical Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What Extra Support Should Clinical Research Teams Offer Participants?
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- What to Consider When Adopting New Technology in Clinical Trials
- What To Look For in an eTMF
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why an eTMF? It’s Time for a Specialized Digital Solution
- Why CRO Staff Need Robust Digital Literacy Skills
- Why Your eTMF Needs Role-Based Access
- World-Class EDC for World-Class Cancer Research Center
eClinical
- 10 Reasons Why We Must Integrate EMR and EDC
- 21st Century Cures Act and Informed Consent in Trials
- 4 Lessons CROs Can Take Away From the COVID-19 Vaccine Trials
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- 5 Ways to Improve the Security of Clinical Trial Data
- Accurate Clinical Trial Forecasting and Budgeting Strategies
- Adaptations of Contract Research Organizations in Virtual Trials
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Attracting and Developing Clinical Research Associates
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Avoiding 5 Pitfalls in Clinical Trial Design
- Benefits and Challenges in Virtual Clinical Trials
- Best Practices for Managing Phase Transition in Adaptive Trials
- Bias in Clinical Trial Incentives
- Changing Stakeholder Relationships in Clinical Trials
- Clinical Research as Care Option for Better Outcomes
- Clinical Trial Costs Keep Rising: How to Fight Back
- Clinical Trial Data Privacy: What Trial Managers Need to Know
- Clinical Trial Under-Enrollment: How to Prevent It
- Collaborating With Key Opinion Leaders in Early Clinical Trial Development: Navigating Risks and Rewards
- Configurability and Customization: Key Features in an eTMF Solution
- COVID-19 Vaccine Development Enables CROs to Optimize Processes
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- CROs’ Guide to Data Protection Officers in Clinical Trials
- Current Event Analysis: Brexit, Clinical Trials and Regulations
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Designing Patient-Friendly Trials for Site Performance
- Discussing Clinical Trial Performance Metrics with Stakeholders
- Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
- Does Your Clinical Trial Need a Chief Patient Experience Officer?
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Ease of Implementation and Customization Spell eTMF Success
- Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop
- Enhancing EHR Use for Efficient Clinical Trials
- Enhancing Trial Planning with Screening and Randomization
- Enhancing Virtual Bedside Manner in Clinical Trials
- eTMF for ALCOA-C Compliance in Clinical Trials
- Evolution of Clinical Trials: Faster Than Ever
- Evolving Needs for CROs: Understanding FDA Expectations
- Expert Hire: Profiles of 5 Top Clinical Research Recruitment Agencies
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- FDA Guidance on Umbrella Trials Can Help CROs Choose the Best Software
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- Getting the Most Out of Your EDC Software
- Global Clinical Trials: Managing Patients and Meeting Compliance
- Global Oncology Community Leveraging Technology for Clinical Trials
- Healthcare Cyberattacks and Clinical Data Management
- How a Real-Time eTMF Dashboard Helps Keep a Trial on Track
- How AI and Machine Learning Are Reshaping Clinical Trials
- How Clinical Trial Organizations Can Convey Trust and Credibility
- How CROs Benefit from Continual Improvement Analysis and Benchmarking
- How CTM Software Can Improve Site Selection For Clinical Trials
- How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How More Data Can Lead to Shorter Clinical Trials
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How the Right Tools Make Clinical Data Integration Seamless
- How Third Party Data Can Improve Clinical Trials
- How to Achieve CTMS Best Practices: Train Your Staff
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- How to Create Social Media Content to Engage Clinical Trials Patients
- How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them
- How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
- How to Improve Patient Retention in Clinical Trials
- How To Improve the Process of Adverse Event Reporting
- How to Improve Trial Site Relationships for More Efficient Trials
- How to Manage Patient Fear Regarding Clinical Trial Risks
- How to Prepare a Successful NDA Submission
- How to Simplify the Clinical Trial Regulatory Submission Process
- How to Use Clinical Oversight Solutions Effectively
- How Will COVID-19 Impact Clinical Trials in the Long Term?
- Improve Clinical Trial Management with Automated CTMS Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Insights on Using Synthetic Data for Clinical Trial Leaders
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- Lightening the Load: Reducing Patient Burden in Clinical Trials
- Managing Multiple Sources within the Clinical Data Ecosystem
- Maximizing Decentralized Trials with Adaptive Systems
- Mental Health Clinical Trials: Controversies, Challenges, Solutions
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Outsourcing Data Management in 2024: Challenges and Benefits
- Overcoming Accessibility Challenges in International Clinical Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Partnering with Patient Advocacy Groups Benefits Pharma and Patients
- Patient Privacy and Cybersecurity in Remote Trials
- Patient-Centric Approach in Clinical Trial Design: Involve Patients Early
- Patient-Centric Clinical Trials: Leveraging Technology for Enhanced Participant Engagement
- Patients as Partners: The Value of Post-Trial Communication
- Precision Medicine: Its Impact on Clinical Trials and Orphan Drugs
- Price Check: How to Cut Costs in Clinical Trials
- Project Management Framework and Tools in Clinical Trials
- Rare Disease Clinical Trials: How to Improve Participation and Outcomes
- Research During a Pandemic: Trial Leadership Supporting Their Teams
- Resolving Patient Reimbursement Challenges in Clinical Trials
- Retaining Trial Participants: Adherence and Dropout Mitigation
- SCOPE 2023 Conference Preview
- Social Media for Clinical Trial Recruitment
- Support for Awareness Campaigns: Good for Pharma and Patients
- Tech Skills and Digital Natives in Demand as Clinical Trial Industry Evolves
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Continuing Rise of Decentralized Clinical Trials
- The FDA Race and Ethnicity Diversity Plan: How to Get Researchers Prepared
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Importance of User Experience in Life Sciences Software
- The Regulations Clinical Researchers Should Track in 2024
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- The Role of Nurse Navigators in Oncology Trials
- The State of Clinical Research During the COVID-19 Pandemic
- The Ugly Truth About Paper Diaries
- Three Ways Decentralized Trials Bolster Patient Recruitment
- Time for Clinical Trials to Deliver on Patient-Centric Care Promises
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Attrition: Gleaning Insights From Patients Who Quit
- Understanding FDA 483: How To Run a Compliant Trial Every Time
- Understanding HHS’ Proposed Rule Changes to HIPAA
- Understanding Risk-Based Clinical Quality Management Technology
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding Security and Role-Based Access in an eTMF Platform
- Understanding the Changing Face of Early Phase Clinical Trials
- Updated FDA Race and Diversity Guidance Open for Comments
- Video Interview: Advancing Clinical Trials with Advanced Technology
- Virtual Reality in Clinical Research: Potential and Challenges
- Voice Tech and Wearables’ Emerging Role in Clinical Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What Extra Support Should Clinical Research Teams Offer Participants?
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- What to Consider When Adopting New Technology in Clinical Trials
- What To Look For in an eTMF
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why an eTMF? It’s Time for a Specialized Digital Solution
- Why CRO Staff Need Robust Digital Literacy Skills
- Why Your eTMF Needs Role-Based Access
- World-Class EDC for World-Class Cancer Research Center
eClinical
- 10 Reasons Why We Must Integrate EMR and EDC
- 21st Century Cures Act and Informed Consent in Trials
- 4 Lessons CROs Can Take Away From the COVID-19 Vaccine Trials
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- 5 Ways to Improve the Security of Clinical Trial Data
- Accurate Clinical Trial Forecasting and Budgeting Strategies
- Adaptations of Contract Research Organizations in Virtual Trials
- Anju Introduces eTMF Master for Electronic Trial Master File Management
- Anju Introduces RTSM Randomization Simulator
- Anju Launches New CRO Partner Program
- Anju Showcases Life Science Solutions at SCDM
- Anju Software Launches a Web-based Coding System
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Anju’s Rapid COVID Study Build in 10 Days with eClinical Suite
- Attracting and Developing Clinical Research Associates
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Avoiding 5 Pitfalls in Clinical Trial Design
- Benefits and Challenges in Virtual Clinical Trials
- Best Practices for Managing Phase Transition in Adaptive Trials
- Bias in Clinical Trial Incentives
- Changing Stakeholder Relationships in Clinical Trials
- Clinical Research as Care Option for Better Outcomes
- Clinical Trial Costs Keep Rising: How to Fight Back
- Clinical Trial Data Privacy: What Trial Managers Need to Know
- Clinical Trial Under-Enrollment: How to Prevent It
- Collaborating With Key Opinion Leaders in Early Clinical Trial Development: Navigating Risks and Rewards
- Configurability and Customization: Key Features in an eTMF Solution
- COVID-19 Vaccine Development Enables CROs to Optimize Processes
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- CROs’ Guide to Data Protection Officers in Clinical Trials
- Current Event Analysis: Brexit, Clinical Trials and Regulations
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Designing Patient-Friendly Trials for Site Performance
- Discussing Clinical Trial Performance Metrics with Stakeholders
- Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
- Does Your Clinical Trial Need a Chief Patient Experience Officer?
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Ease of Implementation and Customization Spell eTMF Success
- Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop
- Enhancing EHR Use for Efficient Clinical Trials
- Enhancing Trial Planning with Screening and Randomization
- Enhancing Virtual Bedside Manner in Clinical Trials
- eTMF for ALCOA-C Compliance in Clinical Trials
- Evolution of Clinical Trials: Faster Than Ever
- Evolving Needs for CROs: Understanding FDA Expectations
- Expert Hire: Profiles of 5 Top Clinical Research Recruitment Agencies
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- FDA Guidance on Umbrella Trials Can Help CROs Choose the Best Software
- FGK Clinical Research Signs Five-Year Agreement with OmniComm
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- Getting the Most Out of Your EDC Software
- Global Clinical Trials: Managing Patients and Meeting Compliance
- Global Oncology Community Leveraging Technology for Clinical Trials
- Gustave Roussy Renews TrialMaster EDC Agreement with Anju
- Healthcare Cyberattacks and Clinical Data Management
- How a Real-Time eTMF Dashboard Helps Keep a Trial on Track
- How AI and Machine Learning Are Reshaping Clinical Trials
- How Clinical Trial Organizations Can Convey Trust and Credibility
- How CROs Benefit from Continual Improvement Analysis and Benchmarking
- How CTM Software Can Improve Site Selection For Clinical Trials
- How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How More Data Can Lead to Shorter Clinical Trials
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How the Right Tools Make Clinical Data Integration Seamless
- How Third Party Data Can Improve Clinical Trials
- How to Achieve CTMS Best Practices: Train Your Staff
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- How to Create Social Media Content to Engage Clinical Trials Patients
- How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them
- How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
- How to Improve Patient Retention in Clinical Trials
- How To Improve the Process of Adverse Event Reporting
- How to Improve Trial Site Relationships for More Efficient Trials
- How to Manage Patient Fear Regarding Clinical Trial Risks
- How to Prepare a Successful NDA Submission
- How to Simplify the Clinical Trial Regulatory Submission Process
- How to Use Clinical Oversight Solutions Effectively
- How Will COVID-19 Impact Clinical Trials in the Long Term?
- Improve Clinical Trial Management with Automated CTMS Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Insights on Using Synthetic Data for Clinical Trial Leaders
- IRTMaster by OmniComm: Accelerating Trial Development
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- Lightening the Load: Reducing Patient Burden in Clinical Trials
- Managing Multiple Sources within the Clinical Data Ecosystem
- Maximizing Decentralized Trials with Adaptive Systems
- Mental Health Clinical Trials: Controversies, Challenges, Solutions
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Outsourcing Data Management in 2024: Challenges and Benefits
- Overcoming Accessibility Challenges in International Clinical Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Partnering with Patient Advocacy Groups Benefits Pharma and Patients
- Patient Privacy and Cybersecurity in Remote Trials
- Patient-Centric Approach in Clinical Trial Design: Involve Patients Early
- Patient-Centric Clinical Trials: Leveraging Technology for Enhanced Participant Engagement
- Patients as Partners: The Value of Post-Trial Communication
- Precision Medicine: Its Impact on Clinical Trials and Orphan Drugs
- Price Check: How to Cut Costs in Clinical Trials
- Project Management Framework and Tools in Clinical Trials
- Rare Disease Clinical Trials: How to Improve Participation and Outcomes
- Research During a Pandemic: Trial Leadership Supporting Their Teams
- Resolving Patient Reimbursement Challenges in Clinical Trials
- Retaining Trial Participants: Adherence and Dropout Mitigation
- SCOPE 2023 Conference Preview
- Social Media for Clinical Trial Recruitment
- Support for Awareness Campaigns: Good for Pharma and Patients
- Tech Skills and Digital Natives in Demand as Clinical Trial Industry Evolves
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Continuing Rise of Decentralized Clinical Trials
- The FDA Race and Ethnicity Diversity Plan: How to Get Researchers Prepared
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Importance of User Experience in Life Sciences Software
- The Regulations Clinical Researchers Should Track in 2024
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- The Role of Nurse Navigators in Oncology Trials
- The State of Clinical Research During the COVID-19 Pandemic
- The Ugly Truth About Paper Diaries
- Three Ways Decentralized Trials Bolster Patient Recruitment
- Time for Clinical Trials to Deliver on Patient-Centric Care Promises
- TrialMaster 5.1: Anju Redefines Clinical Study Build Times
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Attrition: Gleaning Insights From Patients Who Quit
- Understanding FDA 483: How To Run a Compliant Trial Every Time
- Understanding HHS’ Proposed Rule Changes to HIPAA
- Understanding Risk-Based Clinical Quality Management Technology
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding Security and Role-Based Access in an eTMF Platform
- Understanding the Changing Face of Early Phase Clinical Trials
- Updated FDA Race and Diversity Guidance Open for Comments
- Video Interview: Advancing Clinical Trials with Advanced Technology
- Virtual Reality in Clinical Research: Potential and Challenges
- Vita Global Sciences Announces Strategic Partnership with Anju Software
- Voice Tech and Wearables’ Emerging Role in Clinical Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What Extra Support Should Clinical Research Teams Offer Participants?
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- What to Consider When Adopting New Technology in Clinical Trials
- What To Look For in an eTMF
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why an eTMF? It’s Time for a Specialized Digital Solution
- Why CRO Staff Need Robust Digital Literacy Skills
- Why Your eTMF Needs Role-Based Access
- World-Class EDC for World-Class Cancer Research Center
eClinical
- 10 Reasons Why We Must Integrate EMR and EDC
- 21st Century Cures Act and Informed Consent in Trials
- 4 Lessons CROs Can Take Away From the COVID-19 Vaccine Trials
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- 5 Ways to Improve the Security of Clinical Trial Data
- Accurate Clinical Trial Forecasting and Budgeting Strategies
- Adaptations of Contract Research Organizations in Virtual Trials
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Attracting and Developing Clinical Research Associates
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Avoiding 5 Pitfalls in Clinical Trial Design
- Benefits and Challenges in Virtual Clinical Trials
- Best Practices for Managing Phase Transition in Adaptive Trials
- Bias in Clinical Trial Incentives
- Changing Stakeholder Relationships in Clinical Trials
- Clinical Research as Care Option for Better Outcomes
- Clinical Trial Costs Keep Rising: How to Fight Back
- Clinical Trial Data Privacy: What Trial Managers Need to Know
- Clinical Trial Under-Enrollment: How to Prevent It
- Collaborating With Key Opinion Leaders in Early Clinical Trial Development: Navigating Risks and Rewards
- Configurability and Customization: Key Features in an eTMF Solution
- COVID-19 Vaccine Development Enables CROs to Optimize Processes
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- CROs’ Guide to Data Protection Officers in Clinical Trials
- Current Event Analysis: Brexit, Clinical Trials and Regulations
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Designing Patient-Friendly Trials for Site Performance
- Discussing Clinical Trial Performance Metrics with Stakeholders
- Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
- Does Your Clinical Trial Need a Chief Patient Experience Officer?
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Ease of Implementation and Customization Spell eTMF Success
- Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop
- Enhancing EHR Use for Efficient Clinical Trials
- Enhancing Trial Planning with Screening and Randomization
- Enhancing Virtual Bedside Manner in Clinical Trials
- eTMF for ALCOA-C Compliance in Clinical Trials
- Evolution of Clinical Trials: Faster Than Ever
- Evolving Needs for CROs: Understanding FDA Expectations
- Expert Hire: Profiles of 5 Top Clinical Research Recruitment Agencies
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- FDA Guidance on Umbrella Trials Can Help CROs Choose the Best Software
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- Getting the Most Out of Your EDC Software
- Global Clinical Trials: Managing Patients and Meeting Compliance
- Global Oncology Community Leveraging Technology for Clinical Trials
- Healthcare Cyberattacks and Clinical Data Management
- How a Real-Time eTMF Dashboard Helps Keep a Trial on Track
- How AI and Machine Learning Are Reshaping Clinical Trials
- How Clinical Trial Organizations Can Convey Trust and Credibility
- How CROs Benefit from Continual Improvement Analysis and Benchmarking
- How CTM Software Can Improve Site Selection For Clinical Trials
- How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How More Data Can Lead to Shorter Clinical Trials
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How the Right Tools Make Clinical Data Integration Seamless
- How Third Party Data Can Improve Clinical Trials
- How to Achieve CTMS Best Practices: Train Your Staff
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- How to Create Social Media Content to Engage Clinical Trials Patients
- How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them
- How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
- How to Improve Patient Retention in Clinical Trials
- How To Improve the Process of Adverse Event Reporting
- How to Improve Trial Site Relationships for More Efficient Trials
- How to Manage Patient Fear Regarding Clinical Trial Risks
- How to Prepare a Successful NDA Submission
- How to Simplify the Clinical Trial Regulatory Submission Process
- How to Use Clinical Oversight Solutions Effectively
- How Will COVID-19 Impact Clinical Trials in the Long Term?
- Improve Clinical Trial Management with Automated CTMS Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Insights on Using Synthetic Data for Clinical Trial Leaders
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- Lightening the Load: Reducing Patient Burden in Clinical Trials
- Managing Multiple Sources within the Clinical Data Ecosystem
- Maximizing Decentralized Trials with Adaptive Systems
- Mental Health Clinical Trials: Controversies, Challenges, Solutions
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Outsourcing Data Management in 2024: Challenges and Benefits
- Overcoming Accessibility Challenges in International Clinical Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Partnering with Patient Advocacy Groups Benefits Pharma and Patients
- Patient Privacy and Cybersecurity in Remote Trials
- Patient-Centric Approach in Clinical Trial Design: Involve Patients Early
- Patient-Centric Clinical Trials: Leveraging Technology for Enhanced Participant Engagement
- Patients as Partners: The Value of Post-Trial Communication
- Precision Medicine: Its Impact on Clinical Trials and Orphan Drugs
- Price Check: How to Cut Costs in Clinical Trials
- Project Management Framework and Tools in Clinical Trials
- Rare Disease Clinical Trials: How to Improve Participation and Outcomes
- Research During a Pandemic: Trial Leadership Supporting Their Teams
- Resolving Patient Reimbursement Challenges in Clinical Trials
- Retaining Trial Participants: Adherence and Dropout Mitigation
- SCOPE 2023 Conference Preview
- Social Media for Clinical Trial Recruitment
- Support for Awareness Campaigns: Good for Pharma and Patients
- Tech Skills and Digital Natives in Demand as Clinical Trial Industry Evolves
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Continuing Rise of Decentralized Clinical Trials
- The FDA Race and Ethnicity Diversity Plan: How to Get Researchers Prepared
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Importance of User Experience in Life Sciences Software
- The Regulations Clinical Researchers Should Track in 2024
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- The Role of Nurse Navigators in Oncology Trials
- The State of Clinical Research During the COVID-19 Pandemic
- The Ugly Truth About Paper Diaries
- Three Ways Decentralized Trials Bolster Patient Recruitment
- Time for Clinical Trials to Deliver on Patient-Centric Care Promises
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Attrition: Gleaning Insights From Patients Who Quit
- Understanding FDA 483: How To Run a Compliant Trial Every Time
- Understanding HHS’ Proposed Rule Changes to HIPAA
- Understanding Risk-Based Clinical Quality Management Technology
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding Security and Role-Based Access in an eTMF Platform
- Understanding the Changing Face of Early Phase Clinical Trials
- Updated FDA Race and Diversity Guidance Open for Comments
- Video Interview: Advancing Clinical Trials with Advanced Technology
- Virtual Reality in Clinical Research: Potential and Challenges
- Voice Tech and Wearables’ Emerging Role in Clinical Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What Extra Support Should Clinical Research Teams Offer Participants?
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- What to Consider When Adopting New Technology in Clinical Trials
- What To Look For in an eTMF
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why an eTMF? It’s Time for a Specialized Digital Solution
- Why CRO Staff Need Robust Digital Literacy Skills
- Why Your eTMF Needs Role-Based Access
- World-Class EDC for World-Class Cancer Research Center
eClinical
- 10 Reasons Why We Must Integrate EMR and EDC
- 21st Century Cures Act and Informed Consent in Trials
- 4 Lessons CROs Can Take Away From the COVID-19 Vaccine Trials
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- 5 Ways to Improve the Security of Clinical Trial Data
- Accurate Clinical Trial Forecasting and Budgeting Strategies
- Adaptations of Contract Research Organizations in Virtual Trials
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Attracting and Developing Clinical Research Associates
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Avoiding 5 Pitfalls in Clinical Trial Design
- Benefits and Challenges in Virtual Clinical Trials
- Best Practices for Managing Phase Transition in Adaptive Trials
- Beyond Numbers: One Family’s Clinical Trial Journey (Part 1)
- Bias in Clinical Trial Incentives
- Changing Stakeholder Relationships in Clinical Trials
- Clinical Research as Care Option for Better Outcomes
- Clinical Trial Costs Keep Rising: How to Fight Back
- Clinical Trial Data Privacy: What Trial Managers Need to Know
- Clinical Trial Under-Enrollment: How to Prevent It
- Collaborating With Key Opinion Leaders in Early Clinical Trial Development: Navigating Risks and Rewards
- Configurability and Customization: Key Features in an eTMF Solution
- COVID-19 Vaccine Development Enables CROs to Optimize Processes
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- CROs’ Guide to Data Protection Officers in Clinical Trials
- Current Event Analysis: Brexit, Clinical Trials and Regulations
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Designing Patient-Friendly Trials for Site Performance
- Discussing Clinical Trial Performance Metrics with Stakeholders
- Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
- Does Your Clinical Trial Need a Chief Patient Experience Officer?
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Ease of Implementation and Customization Spell eTMF Success
- Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop
- Enhancing EHR Use for Efficient Clinical Trials
- Enhancing Trial Planning with Screening and Randomization
- Enhancing Virtual Bedside Manner in Clinical Trials
- eTMF for ALCOA-C Compliance in Clinical Trials
- Evolution of Clinical Trials: Faster Than Ever
- Evolving Needs for CROs: Understanding FDA Expectations
- Expert Hire: Profiles of 5 Top Clinical Research Recruitment Agencies
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- FDA Guidance on Umbrella Trials Can Help CROs Choose the Best Software
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- Getting the Most Out of Your EDC Software
- Global Clinical Trials: Managing Patients and Meeting Compliance
- Global Oncology Community Leveraging Technology for Clinical Trials
- Healthcare Cyberattacks and Clinical Data Management
- How a Real-Time eTMF Dashboard Helps Keep a Trial on Track
- How AI and Machine Learning Are Reshaping Clinical Trials
- How Clinical Trial Organizations Can Convey Trust and Credibility
- How CROs Benefit from Continual Improvement Analysis and Benchmarking
- How CTM Software Can Improve Site Selection For Clinical Trials
- How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?
- How Does Greater Patient Control of Healthcare Data Impact Clinical Trials?
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How More Data Can Lead to Shorter Clinical Trials
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How the Right Tools Make Clinical Data Integration Seamless
- How Third Party Data Can Improve Clinical Trials
- How to Achieve CTMS Best Practices: Train Your Staff
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- How to Create Social Media Content to Engage Clinical Trials Patients
- How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them
- How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
- How to Improve Patient Retention in Clinical Trials
- How To Improve the Process of Adverse Event Reporting
- How to Improve Trial Site Relationships for More Efficient Trials
- How to Manage Patient Fear Regarding Clinical Trial Risks
- How to Prepare a Successful NDA Submission
- How to Simplify the Clinical Trial Regulatory Submission Process
- How to Use Clinical Oversight Solutions Effectively
- How Will COVID-19 Impact Clinical Trials in the Long Term?
- Improve Clinical Trial Management with Automated CTMS Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Insights on Using Synthetic Data for Clinical Trial Leaders
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- Lightening the Load: Reducing Patient Burden in Clinical Trials
- Managing Multiple Sources within the Clinical Data Ecosystem
- Maximizing Decentralized Trials with Adaptive Systems
- Mental Health Clinical Trials: Controversies, Challenges, Solutions
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Outsourcing Data Management in 2024: Challenges and Benefits
- Overcoming Accessibility Challenges in International Clinical Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Partnering with Patient Advocacy Groups Benefits Pharma and Patients
- Patient Privacy and Cybersecurity in Remote Trials
- Patient-Centric Approach in Clinical Trial Design: Involve Patients Early
- Patient-Centric Clinical Trials: Leveraging Technology for Enhanced Participant Engagement
- Patients as Partners: The Value of Post-Trial Communication
- Precision Medicine: Its Impact on Clinical Trials and Orphan Drugs
- Price Check: How to Cut Costs in Clinical Trials
- Project Management Framework and Tools in Clinical Trials
- Rare Disease Clinical Trials: How to Improve Participation and Outcomes
- Research During a Pandemic: Trial Leadership Supporting Their Teams
- Resolving Patient Reimbursement Challenges in Clinical Trials
- Retaining Trial Participants: Adherence and Dropout Mitigation
- SCOPE 2023 Conference Preview
- Social Media for Clinical Trial Recruitment
- Support for Awareness Campaigns: Good for Pharma and Patients
- Tech Skills and Digital Natives in Demand as Clinical Trial Industry Evolves
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Continuing Rise of Decentralized Clinical Trials
- The FDA Race and Ethnicity Diversity Plan: How to Get Researchers Prepared
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Importance of User Experience in Life Sciences Software
- The Regulations Clinical Researchers Should Track in 2024
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- The Role of Nurse Navigators in Oncology Trials
- The State of Clinical Research During the COVID-19 Pandemic
- The Ugly Truth About Paper Diaries
- Three Ways Decentralized Trials Bolster Patient Recruitment
- Time for Clinical Trials to Deliver on Patient-Centric Care Promises
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Attrition: Gleaning Insights From Patients Who Quit
- Understanding FDA 483: How To Run a Compliant Trial Every Time
- Understanding HHS’ Proposed Rule Changes to HIPAA
- Understanding Risk-Based Clinical Quality Management Technology
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding Security and Role-Based Access in an eTMF Platform
- Understanding the Changing Face of Early Phase Clinical Trials
- Updated FDA Race and Diversity Guidance Open for Comments
- Video Interview: Advancing Clinical Trials with Advanced Technology
- Virtual Reality in Clinical Research: Potential and Challenges
- Voice Tech and Wearables’ Emerging Role in Clinical Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What Extra Support Should Clinical Research Teams Offer Participants?
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- What to Consider When Adopting New Technology in Clinical Trials
- What To Look For in an eTMF
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why an eTMF? It’s Time for a Specialized Digital Solution
- Why CRO Staff Need Robust Digital Literacy Skills
- Why Your eTMF Needs Role-Based Access
- World-Class EDC for World-Class Cancer Research Center
eClinical
- 10 Reasons Why We Must Integrate EMR and EDC
- 21st Century Cures Act and Informed Consent in Trials
- 4 Lessons CROs Can Take Away From the COVID-19 Vaccine Trials
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- 5 Ways to Improve the Security of Clinical Trial Data
- Accurate Clinical Trial Forecasting and Budgeting Strategies
- Adaptations of Contract Research Organizations in Virtual Trials
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Attracting and Developing Clinical Research Associates
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Avoiding 5 Pitfalls in Clinical Trial Design
- Benefits and Challenges in Virtual Clinical Trials
- Best Practices for Managing Phase Transition in Adaptive Trials
- Bias in Clinical Trial Incentives
- Changing Stakeholder Relationships in Clinical Trials
- Clinical Research as Care Option for Better Outcomes
- Clinical Trial Costs Keep Rising: How to Fight Back
- Clinical Trial Data Privacy: What Trial Managers Need to Know
- Clinical Trial Under-Enrollment: How to Prevent It
- Collaborating With Key Opinion Leaders in Early Clinical Trial Development: Navigating Risks and Rewards
- Configurability and Customization: Key Features in an eTMF Solution
- COVID-19 Vaccine Development Enables CROs to Optimize Processes
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- CROs’ Guide to Data Protection Officers in Clinical Trials
- Current Event Analysis: Brexit, Clinical Trials and Regulations
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Designing Patient-Friendly Trials for Site Performance
- Discussing Clinical Trial Performance Metrics with Stakeholders
- Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
- Does Your Clinical Trial Need a Chief Patient Experience Officer?
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Ease of Implementation and Customization Spell eTMF Success
- eConsent: Definitions & Details
- Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop
- Enhancing EHR Use for Efficient Clinical Trials
- Enhancing Trial Planning with Screening and Randomization
- Enhancing Virtual Bedside Manner in Clinical Trials
- eTMF for ALCOA-C Compliance in Clinical Trials
- Evolution of Clinical Trials: Faster Than Ever
- Evolving Needs for CROs: Understanding FDA Expectations
- Expert Hire: Profiles of 5 Top Clinical Research Recruitment Agencies
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- FDA Guidance on Umbrella Trials Can Help CROs Choose the Best Software
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- Getting the Most Out of Your EDC Software
- Global Clinical Trials: Managing Patients and Meeting Compliance
- Global Oncology Community Leveraging Technology for Clinical Trials
- Healthcare Cyberattacks and Clinical Data Management
- How a Real-Time eTMF Dashboard Helps Keep a Trial on Track
- How AI and Machine Learning Are Reshaping Clinical Trials
- How Clinical Trial Organizations Can Convey Trust and Credibility
- How CROs Benefit from Continual Improvement Analysis and Benchmarking
- How CTM Software Can Improve Site Selection For Clinical Trials
- How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How More Data Can Lead to Shorter Clinical Trials
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How the Right Tools Make Clinical Data Integration Seamless
- How Third Party Data Can Improve Clinical Trials
- How to Achieve CTMS Best Practices: Train Your Staff
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- How to Create Social Media Content to Engage Clinical Trials Patients
- How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them
- How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
- How to Improve Patient Retention in Clinical Trials
- How To Improve the Process of Adverse Event Reporting
- How to Improve Trial Site Relationships for More Efficient Trials
- How to Manage Patient Fear Regarding Clinical Trial Risks
- How to Prepare a Successful NDA Submission
- How to Simplify the Clinical Trial Regulatory Submission Process
- How to Use Clinical Oversight Solutions Effectively
- How Will COVID-19 Impact Clinical Trials in the Long Term?
- Improve Clinical Trial Management with Automated CTMS Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Insights on Using Synthetic Data for Clinical Trial Leaders
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- Lightening the Load: Reducing Patient Burden in Clinical Trials
- Managing Multiple Sources within the Clinical Data Ecosystem
- Maximizing Decentralized Trials with Adaptive Systems
- Mental Health Clinical Trials: Controversies, Challenges, Solutions
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Outsourcing Data Management in 2024: Challenges and Benefits
- Overcoming Accessibility Challenges in International Clinical Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Partnering with Patient Advocacy Groups Benefits Pharma and Patients
- Patient Privacy and Cybersecurity in Remote Trials
- Patient-Centric Approach in Clinical Trial Design: Involve Patients Early
- Patient-Centric Clinical Trials: Leveraging Technology for Enhanced Participant Engagement
- Patients as Partners: The Value of Post-Trial Communication
- Precision Medicine: Its Impact on Clinical Trials and Orphan Drugs
- Price Check: How to Cut Costs in Clinical Trials
- Project Management Framework and Tools in Clinical Trials
- Rare Disease Clinical Trials: How to Improve Participation and Outcomes
- Research During a Pandemic: Trial Leadership Supporting Their Teams
- Resolving Patient Reimbursement Challenges in Clinical Trials
- Retaining Trial Participants: Adherence and Dropout Mitigation
- SCOPE 2023 Conference Preview
- Social Media for Clinical Trial Recruitment
- Support for Awareness Campaigns: Good for Pharma and Patients
- Tech Skills and Digital Natives in Demand as Clinical Trial Industry Evolves
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Continuing Rise of Decentralized Clinical Trials
- The FDA Race and Ethnicity Diversity Plan: How to Get Researchers Prepared
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Importance of User Experience in Life Sciences Software
- The Regulations Clinical Researchers Should Track in 2024
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- The Role of Nurse Navigators in Oncology Trials
- The State of Clinical Research During the COVID-19 Pandemic
- The Ugly Truth About Paper Diaries
- Three Ways Decentralized Trials Bolster Patient Recruitment
- Time for Clinical Trials to Deliver on Patient-Centric Care Promises
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Attrition: Gleaning Insights From Patients Who Quit
- Understanding FDA 483: How To Run a Compliant Trial Every Time
- Understanding HHS’ Proposed Rule Changes to HIPAA
- Understanding Risk-Based Clinical Quality Management Technology
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding Security and Role-Based Access in an eTMF Platform
- Understanding the Changing Face of Early Phase Clinical Trials
- Updated FDA Race and Diversity Guidance Open for Comments
- Video Interview: Advancing Clinical Trials with Advanced Technology
- Virtual Reality in Clinical Research: Potential and Challenges
- Voice Tech and Wearables’ Emerging Role in Clinical Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What Extra Support Should Clinical Research Teams Offer Participants?
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- What to Consider When Adopting New Technology in Clinical Trials
- What To Look For in an eTMF
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why an eTMF? It’s Time for a Specialized Digital Solution
- Why CRO Staff Need Robust Digital Literacy Skills
- Why Your eTMF Needs Role-Based Access
- World-Class EDC for World-Class Cancer Research Center
eClinical
- 10 Reasons Why We Must Integrate EMR and EDC
- 21st Century Cures Act and Informed Consent in Trials
- 4 Lessons CROs Can Take Away From the COVID-19 Vaccine Trials
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- 5 Ways to Improve the Security of Clinical Trial Data
- Accurate Clinical Trial Forecasting and Budgeting Strategies
- Adaptations of Contract Research Organizations in Virtual Trials
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Attracting and Developing Clinical Research Associates
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Avoiding 5 Pitfalls in Clinical Trial Design
- Benefits and Challenges in Virtual Clinical Trials
- Best Practices for Managing Phase Transition in Adaptive Trials
- Bias in Clinical Trial Incentives
- Changing Stakeholder Relationships in Clinical Trials
- Clinical Research as Care Option for Better Outcomes
- Clinical Trial Costs Keep Rising: How to Fight Back
- Clinical Trial Data Privacy: What Trial Managers Need to Know
- Clinical Trial Under-Enrollment: How to Prevent It
- Collaborating With Key Opinion Leaders in Early Clinical Trial Development: Navigating Risks and Rewards
- Configurability and Customization: Key Features in an eTMF Solution
- COVID-19 Vaccine Development Enables CROs to Optimize Processes
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- CROs’ Guide to Data Protection Officers in Clinical Trials
- Current Event Analysis: Brexit, Clinical Trials and Regulations
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Designing Patient-Friendly Trials for Site Performance
- Discussing Clinical Trial Performance Metrics with Stakeholders
- Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
- Does Your Clinical Trial Need a Chief Patient Experience Officer?
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Ease of Implementation and Customization Spell eTMF Success
- Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop
- Enhancing EHR Use for Efficient Clinical Trials
- Enhancing Trial Planning with Screening and Randomization
- Enhancing Virtual Bedside Manner in Clinical Trials
- eTMF for ALCOA-C Compliance in Clinical Trials
- Evolution of Clinical Trials: Faster Than Ever
- Evolving Needs for CROs: Understanding FDA Expectations
- Expert Hire: Profiles of 5 Top Clinical Research Recruitment Agencies
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- FDA Guidance on Umbrella Trials Can Help CROs Choose the Best Software
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- Getting the Most Out of Your EDC Software
- Global Clinical Trials: Managing Patients and Meeting Compliance
- Global Oncology Community Leveraging Technology for Clinical Trials
- Healthcare Cyberattacks and Clinical Data Management
- How a Real-Time eTMF Dashboard Helps Keep a Trial on Track
- How AI and Machine Learning Are Reshaping Clinical Trials
- How Clinical Trial Organizations Can Convey Trust and Credibility
- How CROs Benefit from Continual Improvement Analysis and Benchmarking
- How CTM Software Can Improve Site Selection For Clinical Trials
- How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How More Data Can Lead to Shorter Clinical Trials
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How the Right Tools Make Clinical Data Integration Seamless
- How Third Party Data Can Improve Clinical Trials
- How to Achieve CTMS Best Practices: Train Your Staff
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- How to Create Social Media Content to Engage Clinical Trials Patients
- How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them
- How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
- How to Improve Patient Retention in Clinical Trials
- How To Improve the Process of Adverse Event Reporting
- How to Improve Trial Site Relationships for More Efficient Trials
- How to Manage Patient Fear Regarding Clinical Trial Risks
- How to Prepare a Successful NDA Submission
- How to Simplify the Clinical Trial Regulatory Submission Process
- How to Use Clinical Oversight Solutions Effectively
- How Will COVID-19 Impact Clinical Trials in the Long Term?
- Improve Clinical Trial Management with Automated CTMS Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Insights on Using Synthetic Data for Clinical Trial Leaders
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- Lightening the Load: Reducing Patient Burden in Clinical Trials
- Managing Multiple Sources within the Clinical Data Ecosystem
- Maximizing Decentralized Trials with Adaptive Systems
- Mental Health Clinical Trials: Controversies, Challenges, Solutions
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Optimize Clinical Study Design With Randomization Simulation
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Outsourcing Data Management in 2024: Challenges and Benefits
- Overcoming Accessibility Challenges in International Clinical Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Partnering with Patient Advocacy Groups Benefits Pharma and Patients
- Patient Privacy and Cybersecurity in Remote Trials
- Patient-Centric Approach in Clinical Trial Design: Involve Patients Early
- Patient-Centric Clinical Trials: Leveraging Technology for Enhanced Participant Engagement
- Patients as Partners: The Value of Post-Trial Communication
- Precision Medicine: Its Impact on Clinical Trials and Orphan Drugs
- Price Check: How to Cut Costs in Clinical Trials
- Project Management Framework and Tools in Clinical Trials
- Rare Disease Clinical Trials: How to Improve Participation and Outcomes
- Research During a Pandemic: Trial Leadership Supporting Their Teams
- Resolving Patient Reimbursement Challenges in Clinical Trials
- Retaining Trial Participants: Adherence and Dropout Mitigation
- SCOPE 2023 Conference Preview
- Social Media for Clinical Trial Recruitment
- Support for Awareness Campaigns: Good for Pharma and Patients
- Tech Skills and Digital Natives in Demand as Clinical Trial Industry Evolves
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Continuing Rise of Decentralized Clinical Trials
- The FDA Race and Ethnicity Diversity Plan: How to Get Researchers Prepared
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Importance of User Experience in Life Sciences Software
- The Regulations Clinical Researchers Should Track in 2024
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- The Role of Nurse Navigators in Oncology Trials
- The State of Clinical Research During the COVID-19 Pandemic
- The Ugly Truth About Paper Diaries
- Three Ways Decentralized Trials Bolster Patient Recruitment
- Time for Clinical Trials to Deliver on Patient-Centric Care Promises
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Attrition: Gleaning Insights From Patients Who Quit
- Understanding FDA 483: How To Run a Compliant Trial Every Time
- Understanding HHS’ Proposed Rule Changes to HIPAA
- Understanding Risk-Based Clinical Quality Management Technology
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding Security and Role-Based Access in an eTMF Platform
- Understanding the Changing Face of Early Phase Clinical Trials
- Updated FDA Race and Diversity Guidance Open for Comments
- Video Interview: Advancing Clinical Trials with Advanced Technology
- Virtual Reality in Clinical Research: Potential and Challenges
- Voice Tech and Wearables’ Emerging Role in Clinical Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What Extra Support Should Clinical Research Teams Offer Participants?
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- What to Consider When Adopting New Technology in Clinical Trials
- What To Look For in an eTMF
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why an eTMF? It’s Time for a Specialized Digital Solution
- Why CRO Staff Need Robust Digital Literacy Skills
- Why Your eTMF Needs Role-Based Access
- World-Class EDC for World-Class Cancer Research Center
eCOA
EDC
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Avoiding 5 Pitfalls in Clinical Trial Design
- Best Practices for Managing Phase Transition in Adaptive Trials
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Designing Patient-Friendly Trials for Site Performance
- Discussing Clinical Trial Performance Metrics with Stakeholders
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Evolution of Clinical Trials: Faster Than Ever
- Getting the Most Out of Your EDC Software
- Global Oncology Community Leveraging Technology for Clinical Trials
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How To Improve the Process of Adverse Event Reporting
- How to Prepare a Successful NDA Submission
- How to Use Clinical Oversight Solutions Effectively
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Price Check: How to Cut Costs in Clinical Trials
- SCOPE 2023 Conference Preview
- Social Media for Clinical Trial Recruitment
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Importance of User Experience in Life Sciences Software
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding the Changing Face of Early Phase Clinical Trials
- Video Interview: Advancing Clinical Trials with Advanced Technology
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- Why CRO Staff Need Robust Digital Literacy Skills
EDC
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- Anju Launches New CRO Partner Program
- Anju Showcases Life Science Solutions at SCDM
- Anju Software Launches a Web-based Coding System
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Anju’s Rapid COVID Study Build in 10 Days with eClinical Suite
- Avoiding 5 Pitfalls in Clinical Trial Design
- Best Practices for Managing Phase Transition in Adaptive Trials
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Designing Patient-Friendly Trials for Site Performance
- Discussing Clinical Trial Performance Metrics with Stakeholders
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Evolution of Clinical Trials: Faster Than Ever
- FGK Clinical Research Signs Five-Year Agreement with OmniComm
- Getting the Most Out of Your EDC Software
- Global Oncology Community Leveraging Technology for Clinical Trials
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How To Improve the Process of Adverse Event Reporting
- How to Prepare a Successful NDA Submission
- How to Use Clinical Oversight Solutions Effectively
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Price Check: How to Cut Costs in Clinical Trials
- SCOPE 2023 Conference Preview
- Social Media for Clinical Trial Recruitment
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Importance of User Experience in Life Sciences Software
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding the Changing Face of Early Phase Clinical Trials
- Video Interview: Advancing Clinical Trials with Advanced Technology
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- Why CRO Staff Need Robust Digital Literacy Skills
EDC
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Avoiding 5 Pitfalls in Clinical Trial Design
- Best Practices for Managing Phase Transition in Adaptive Trials
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Designing Patient-Friendly Trials for Site Performance
- Discussing Clinical Trial Performance Metrics with Stakeholders
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Evolution of Clinical Trials: Faster Than Ever
- Getting the Most Out of Your EDC Software
- Global Oncology Community Leveraging Technology for Clinical Trials
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How To Improve the Process of Adverse Event Reporting
- How to Prepare a Successful NDA Submission
- How to Use Clinical Oversight Solutions Effectively
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Price Check: How to Cut Costs in Clinical Trials
- SCOPE 2023 Conference Preview
- Social Media for Clinical Trial Recruitment
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Importance of User Experience in Life Sciences Software
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding the Changing Face of Early Phase Clinical Trials
- Video Interview: Advancing Clinical Trials with Advanced Technology
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- Why CRO Staff Need Robust Digital Literacy Skills
EDC
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- Anju at DIA 2021 Global Annual Meeting
- Anju at DIA China: Utilizing Clinical Trial Technology
- Anju Showcases Life Science Solutions at SCDM
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Avoiding 5 Pitfalls in Clinical Trial Design
- Best Practices for Managing Phase Transition in Adaptive Trials
- ClinChoice & Anju Partner: Life Science Information Management
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Designing Patient-Friendly Trials for Site Performance
- DIA Global Trial Disclosure & Data Conference
- Discussing Clinical Trial Performance Metrics with Stakeholders
- DMB Conference in Paris This November: Celebrating 25 Years
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Evolution of Clinical Trials: Faster Than Ever
- Getting the Most Out of Your EDC Software
- Global Oncology Community Leveraging Technology for Clinical Trials
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How To Improve the Process of Adverse Event Reporting
- How to Prepare a Successful NDA Submission
- How to Use Clinical Oversight Solutions Effectively
- Insights from DIA 2019 Global Annual Meeting
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Join Anju at OCT Europe for Best Practices in Utilizing Decentralized Trials Technology
- Join Anju at OCT West Coast: Decentralized Trials
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- Message to Clients – COVID-19
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Price Check: How to Cut Costs in Clinical Trials
- SCOPE 2023 Conference Preview
- SCOPE Summit 2020: Anju’s eClinical Solutions
- Social Media for Clinical Trial Recruitment
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Importance of User Experience in Life Sciences Software
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- There is no other event like DIA 2019 Global Annual Meeting
- Top Events and Speakers at the DIA 2022 Global Annual Meeting
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding the Changing Face of Early Phase Clinical Trials
- Video Interview: Advancing Clinical Trials with Advanced Technology
- Visit us at The PharmaSUG 2019: June 16-19 in Philadelphia
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- Why CRO Staff Need Robust Digital Literacy Skills
eTMF
- Anju Introduces eTMF Master for Electronic Trial Master File Management
- Configurability and Customization: Key Features in an eTMF Solution
- Ease of Implementation and Customization Spell eTMF Success
- eTMF for ALCOA-C Compliance in Clinical Trials
- Gustave Roussy Renews TrialMaster EDC Agreement with Anju
- How a Real-Time eTMF Dashboard Helps Keep a Trial on Track
- How to Improve Trial Site Relationships for More Efficient Trials
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Project Management Framework and Tools in Clinical Trials
- SCOPE 2023 Conference Preview
- TrialMaster 5.1: Anju Redefines Clinical Study Build Times
- Understanding Security and Role-Based Access in an eTMF Platform
- What To Look For in an eTMF
- Why an eTMF? It’s Time for a Specialized Digital Solution
- Why Your eTMF Needs Role-Based Access
- World-Class EDC for World-Class Cancer Research Center
eTMF
- Configurability and Customization: Key Features in an eTMF Solution
- Ease of Implementation and Customization Spell eTMF Success
- eTMF for ALCOA-C Compliance in Clinical Trials
- How a Real-Time eTMF Dashboard Helps Keep a Trial on Track
- How to Improve Trial Site Relationships for More Efficient Trials
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Project Management Framework and Tools in Clinical Trials
- SCOPE 2023 Conference Preview
- Understanding Security and Role-Based Access in an eTMF Platform
- What To Look For in an eTMF
- Why an eTMF? It’s Time for a Specialized Digital Solution
- Why Your eTMF Needs Role-Based Access
- World-Class EDC for World-Class Cancer Research Center
Feasibility
- Analysis performed by Anju via TA Scan on COVID-19
- How Do We Solve Pharma’s Data Dysfunction Conundrum?
- How Historical Data and Controls Improve Clinical Trials
- International Research Collaboration: What Tools Can Help
- Laurence Birch Interview: Adaptive Life Sciences Tech
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
- Trial Eligibility Criteria: The Problem with Current Exclusion Strategies
- Using AI to Formulate Clinical Trial Research Questions
Feasibility
- Adaptive Data Analysis Changing World – Anju
- Analysis performed by Anju via TA Scan on COVID-19
- How Do We Solve Pharma’s Data Dysfunction Conundrum?
- How Historical Data and Controls Improve Clinical Trials
- International Research Collaboration: What Tools Can Help
- Laurence Birch Interview: Adaptive Life Sciences Tech
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
- Trial Eligibility Criteria: The Problem with Current Exclusion Strategies
- Using AI to Formulate Clinical Trial Research Questions
General
- 2019 Exhibitions and Events: Important Healthcare IT Conferences
- Anju Acquires Zephyr Health
- Anju Advances Life Science Software and Data Through Acquisition of MDCPartners
- Anju Appoints Laurence Birch as Chief Executive Officer
- Anju Boosts Life Science Portfolio with OpenQ Acquisition
- Anju Completes Merger with OmniComm Systems
- Anju Enters Clinical Trial Software: ClinPlus Acquisition
- Anju Featured in CIO Review
- Anju Innovation Forum Day 2 Highlights
- Anju Innovation Forum Day 3 Highlights
- Anju Launches Life Sciences Big Data Management Platform
- Anju Recognized in Gartner’s 2021 Hype Cycle
- Anju Software Recapitalizes with Abry Partners
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- Anju’s Presence at DIA 2023 Global Annual Meeting
- INSIGHTS from ISMPP EU
- Joe Alea Appointed EVP of Product Development at Anju
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Steve Rosenberg Joins Anju’s Board of Directors
- Top 2020 Conferences CROs Should Not Miss
- Update on the Apache Log4j Security Vulnerability
General
- 2019 Exhibitions and Events: Important Healthcare IT Conferences
- Anju Innovation Forum Day 2 Highlights
- Anju Innovation Forum Day 3 Highlights
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- Anju’s Growth Strategy: CEO’s Perspective
- INSIGHTS from ISMPP EU
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Top 2020 Conferences CROs Should Not Miss
General
- 2019 Exhibitions and Events: Important Healthcare IT Conferences
- Anju Innovation Forum Day 2 Highlights
- Anju Innovation Forum Day 3 Highlights
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- INSIGHTS from ISMPP EU
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Top 2020 Conferences CROs Should Not Miss
General
- 10 Global Medical Affairs Conferences to Attend in 2020
- 10 Medical Affairs Conferences in Late 2020 and Early 2021
- 2019 Exhibitions and Events: Important Healthcare IT Conferences
- 2020 Conferences for CROs and Clinical Trial Professionals
- Anju Innovation Forum Day 1 Highlights
- Anju Innovation Forum Day 2 Highlights
- Anju Innovation Forum Day 3 Highlights
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- INSIGHTS from ISMPP EU
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Meet Anju’s Data Division at Eyeforpharma Philadelphia 2019
- Meet Anju’s Data Divison at Eyeforpharma Barcelona 2019
- Merck Technology Symposium 2019
- Top 2020 Conferences CROs Should Not Miss
Insights
- 10 Global Medical Affairs Conferences to Attend in 2020
- 10 Medical Affairs Conferences in Late 2020 and Early 2021
- 10 Reasons Why We Must Integrate EMR and EDC
- 2019 Exhibitions and Events: Important Healthcare IT Conferences
- 21st Century Cures Act and Informed Consent in Trials
- 3 Tips to Perform a Disease Landscaping Analysis
- 4 Lessons CROs Can Take Away From the COVID-19 Vaccine Trials
- 4 Ways an IRMS Helps Medical Affairs Manage and Share Insights
- 5 Skills That Tomorrow’s Data Managers Will Need to Succeed
- 5 Strategies to Engage Digital Opinion Leaders
- 5 Things Medical Affairs Can Do to Support Late Life Cycle Drugs
- 5 Ways to Improve the Security of Clinical Trial Data
- 6th European Clinical Research Conference: Presentations
- A Global Approach: Clinical Trials in Emerging Markets
- Accurate Clinical Trial Forecasting and Budgeting Strategies
- Achieving Data Compliance in Decentralized Trials
- Achieving Transparency: Why and How to Share Trial Results Data
- Adaptations of Contract Research Organizations in Virtual Trials
- AI and Clinical Intelligence in Oncology Research
- AI and ML in Clinical Data Management
- Analysis performed by Anju via TA Scan on COVID-19
- Anju Innovation Forum Day 2 Highlights
- Anju Innovation Forum Day 3 Highlights
- Anju Showcases Life Science Solutions at SCDM
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- Anju to Exhibit at MAPS 2024 in Puerto Rico
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Anju’s TA Scan Analysis of COVID-19 Update
- Anju’s TA Scan Selected by Leading Pharma Company to Enhance Clinical Research
- Attracting and Developing Clinical Research Associates
- Automated Clinical Data Exchange for Collaboration in Clinical Trials
- Automation, Analytics, AI and the Future of Trial Monitoring
- Avoiding 5 Pitfalls in Clinical Trial Design
- Benefits and Challenges in Virtual Clinical Trials
- Best Practices for Managing Phase Transition in Adaptive Trials
- Best Practices of Medical Affairs Publication Planning in 2021
- Bias in Clinical Trial Incentives
- Breaking Down Data Silos in Life Sciences
- Building a Strong Foundation for Medical Affairs Leadership
- Building Opinion Leader Relationships in a Post-Pandemic World
- CBI’s Medical Publications Forum Insights
- Changing Stakeholder Relationships in Clinical Trials
- Choosing a Medical Affairs CRM Platform: Key Considerations
- Chronic Obstructive Pulmonary Disease: Latest Clinical Data
- Clinical Data Analysis: 3 Most Important Frontiers Right Now
- Clinical Research as Care Option for Better Outcomes
- Clinical Trial & Therapy Results: Anju’s Pubstrat MAX
- Clinical Trial Compliance Auditing: Challenges and Tools
- Clinical Trial Costs Keep Rising: How to Fight Back
- Clinical Trial Data Privacy: What Trial Managers Need to Know
- Clinical Trial Data Sharing: Medical Affairs’ Role
- Clinical Trial Under-Enrollment: How to Prevent It
- Collaborating With Key Opinion Leaders in Early Clinical Trial Development: Navigating Risks and Rewards
- Collaboration Opportunities Between Regulators and Medical Affairs
- Community Pharmacies and Clinical Trial Enrollment
- Conference Preview: ISMPP Europe 2024
- Configurability and Customization: Key Features in an eTMF Solution
- COVID-19 Vaccine Development Enables CROs to Optimize Processes
- COVID-19 Vaccine’s Impact on the Role of Medical Affairs
- COVID-19: Clear, Accessible Science’s Importance
- COVID-19’s Impact on Data Collection in Trials
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- COVID: The Role of Medical Affairs Teams in Public Health
- CROs’ Guide to Data Protection Officers in Clinical Trials
- Current Event Analysis: Brexit, Clinical Trials and Regulations
- Data Analysis on Latest Clinical Research for Parkinson’s Day
- Data Analysis on Research for Multiple Sclerosis Day
- Data Interoperability and Sharing: Practical Considerations
- Data Protection in Medical Affairs: Basic Cybersecurity
- Decentralized Clinical Trials: Post-COVID Future
- Decentralized Trials: Bridging Distances in COVID-19
- Decentralized Trials: Combating Bias and Reaching Diverse Patients
- Deeper KOL Connections: How Information Design Empowers Medical Affairs
- Designing Patient-Friendly Trials for Site Performance
- Digital Opinion Leaders in Post-COVID Medical Affairs
- Discussing Clinical Trial Performance Metrics with Stakeholders
- Diverse Clinical Trials: A Necessity for Personalized Medicine
- Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
- Do You Have a Selection Strategy for Your Clinical Trial Endpoints?
- Does Your Clinical Trial Need a Chief Patient Experience Officer?
- Drug Labeling Trends: Making Language Accessible to Patients
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Early-Stage Decentralized Clinical Trial Site Selection: Key Factors
- Ease of Implementation and Customization Spell eTMF Success
- Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop
- Enhancing EHR Use for Efficient Clinical Trials
- Enhancing Trial Planning with Screening and Randomization
- Enhancing Virtual Bedside Manner in Clinical Trials
- eTMF for ALCOA-C Compliance in Clinical Trials
- Evolution of Clinical Trials: Faster Than Ever
- Evolving Needs for CROs: Understanding FDA Expectations
- Experimental Design: New Therapies Are Being Developed to Treat Lifelong Illness
- Expert Hire: Profiles of 5 Top Clinical Research Recruitment Agencies
- Explore Anju’s AI Roadmap at the 20th Annual Meeting of ISMPP
- FDA Guidance and Clinical Trial Innovation: Who’s Setting the Pace?
- FDA Guidance on Umbrella Trials Can Help CROs Choose the Best Software
- Forbes Ranks Virtual Trials as a Top 5 Digital Health Technology Trend
- Future of Decentralized Trials: Anju EVP’s Predictions
- Geriatric Research: Why Your Study Should Include More Seniors
- Getting the Most Out of Your EDC Software
- Global Clinical Trials: Managing Patients and Meeting Compliance
- Global Oncology Community Leveraging Technology for Clinical Trials
- Healthcare Cyberattacks and Clinical Data Management
- How a Real-Time eTMF Dashboard Helps Keep a Trial on Track
- How AI and Machine Learning Are Reshaping Clinical Trials
- How Automated Site Visit Reports Improve Clinical Trials
- How Big Data and AI Are Changing the Role of Medical Affairs & Pharma
- How Clinical Trial Organizations Can Convey Trust and Credibility
- How CROs Benefit from Continual Improvement Analysis and Benchmarking
- How CTM Software Can Improve Site Selection For Clinical Trials
- How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?
- How Do We Solve Pharma’s Data Dysfunction Conundrum?
- How Efficiencies in Trial Builds Facilitate Quicker Data Collection
- How Electronic Data Capture Software Facilitates Cleaner Trial Data
- How GDPR is Affecting Clinical Trials
- How Historical Data and Controls Improve Clinical Trials
- How Medical Affairs Can Amplify the Patient Voice
- How Medical Affairs Can Support a Product Against New Competition
- How Medical Affairs Can Support Pharma Marketing
- How Medical Affairs Can Use Tech to Provide Medical Information Letters
- How Medical Affairs Teams Can Advocate for Patient-Centric Healthcare
- How Medical Affairs Teams Can Boost Stakeholder Engagement
- How Medical Affairs Teams Can Help Get Off-Label Drugs to Patients
- How Medical Affairs Teams Can Improve Their Digital Communications
- How Medical Affairs Teams Can Optimize Product Life Cycle
- How Medical Science Liaisons Should Engage With Key Opinion Leaders
- How More Data Can Lead to Shorter Clinical Trials
- How MSLs Became Pharma’s Essential Information Contact Point
- How Patient Voices Power Pharmaceutical Innovation
- How Patient-Centricity is Becoming a Cliche and The Crucial Tool in Anju’s Arsenal
- How Researchers Address Patient Tech Fatigue in Decentralized Trials
- How Risk-Based Monitoring Can Improve Clinical Trial Operations
- How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
- How Technology is Moving Decentralized Clinical Trials Forward
- How the Right Software Can Help Small Biopharma Companies Succeed
- How the Right Tools Make Clinical Data Integration Seamless
- How Third Party Data Can Improve Clinical Trials
- How to Achieve CTMS Best Practices: Train Your Staff
- How to Best Ensure Accuracy in Coding for Clinical Trials
- How to Build Flexible Clinical Trial Design — and How Software Can Help
- How to Create an Effective Risk-Based Monitoring Plan
- How to Create Social Media Content to Engage Clinical Trials Patients
- How To Empower Medical Science Liaisons With Data, and Why You Should
- How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them
- How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
- How to Improve Patient Retention in Clinical Trials
- How To Improve the Process of Adverse Event Reporting
- How to Improve Trial Site Relationships for More Efficient Trials
- How to Manage Patient Fear Regarding Clinical Trial Risks
- How to Measure the Effectiveness of Medical Information Distribution
- How to Prepare a Successful NDA Submission
- How To Prevent Systemic Bias in Clinical Trials
- How to Simplify the Clinical Trial Regulatory Submission Process
- How to Use Clinical Oversight Solutions Effectively
- How Trial Managers Can Increase Diversity in Clinical Trials
- How Will COVID-19 Impact Clinical Trials in the Long Term?
- Human Analysis Crucial in AI-Driven Data Management
- Impact of Cybersecurity and Data Privacy on Medical Affairs Teams
- Improve Clinical Trial Management with Automated CTMS Tools
- Improve MA Decision-Making With Advanced Business Intelligence Tools
- In a Data-Rich Landscape, a Single Source of Truth is Key
- Informed Site Selection is Mission Critical in Post COVID-19 Era
- INSIGHTS from DIA 2019 MICC
- INSIGHTS from ISMPP EU
- Insights into the 2023 ASCO Annual Meeting
- Insights on Using Synthetic Data for Clinical Trial Leaders
- International Research Collaboration: What Tools Can Help
- Is Lack of Data Integration Undermining Your Medical Affairs Efforts?
- Is There a Place for Integrative Medicine Approaches in Clinical Trials?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Legal Questions Shaping Clinical Research
- Lightening the Load: Reducing Patient Burden in Clinical Trials
- Machine Learning and KOL Networks: The Future of Medical Affairs
- Maintain Remote Professional Relationships: 3 Tips for Medical Affairs
- Managing Multiple Sources within the Clinical Data Ecosystem
- Maximize Product Launch Success with Connected Clinical and Commercial Strategies
- Maximizing Decentralized Trials with Adaptive Systems
- Medical Affairs KPIs: How to Create a Framework For Measuring Success
- Medical Affairs Leads COVID-19 Response
- Medical Affairs Provides Credible Consumer Information
- Medical Information Management: Balancing Security With Accessibility
- Medical Publishing: How the Right Tools Maximize Your Deliverable’s Reach
- Medical Research and Publishing Has Exploded: How Are You Managing Knowledge?
- Meeting KOLs via Data Makes Initial Communications More Meaningful, Builds Relationships
- Mental Health Clinical Trials: Controversies, Challenges, Solutions
- Mike Keens on Clinical Trials Podcast
- More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
- New Shifts In The Medical Affairs Ecosystem
- New Technology & the Global COVID Pandemic Drive the Need for More Decentralized Trials
- Optimizing Clinical Trial Outcomes Through Predictive Enrollment Strategies
- Optimizing Outreach: Effective Communication Strategies for Medical Affairs Teams in 2024
- Our Most Anticipated Events at DIA MASC 2023
- Outsourcing Clinical Trials: How to Build Successful Partnerships
- Outsourcing Data Management in 2024: Challenges and Benefits
- Overcoming Accessibility Challenges in International Clinical Trials
- Overcoming Data Management Challenges in Self-Reporting Clinical Trials
- Overcoming Language and Culture Barriers in Multinational Clinical Trials
- Pandemic-Driven Medical Affairs and Scientific Insights Management
- Partnering with Patient Advocacy Groups Benefits Pharma and Patients
- Patient Privacy and Cybersecurity in Remote Trials
- Patient-Centric Approach in Clinical Trial Design: Involve Patients Early
- Patient-Centric Clinical Trials: Leveraging Technology for Enhanced Participant Engagement
- Patients as Partners: The Value of Post-Trial Communication
- Precision Medicine: Its Impact on Clinical Trials and Orphan Drugs
- Preview: 6 Sessions at DIA Medical Information Conference
- Price Check: How to Cut Costs in Clinical Trials
- Project Management Framework and Tools in Clinical Trials
- Promoting Value-Based Clinical Trials in Medical Affairs
- Public Health Misinformation: What Can Medical Affairs Teams Do?
- Publicizing Research: Reach Audiences and Combat Misinformation
- Rare Disease Clinical Trials: Challenges and Opportunities Researchers Face
- Rare Disease Clinical Trials: How to Improve Participation and Outcomes
- Research During a Pandemic: Trial Leadership Supporting Their Teams
- Researchers Whose Work May Lead to Cancer Treatment Breakthroughs
- Resolving Patient Reimbursement Challenges in Clinical Trials
- Retaining Trial Participants: Adherence and Dropout Mitigation
- Revolutionizing Clinical Research: The Role of Generative AI
- Science Behind the Comms: How MA Teams Add Value to Messaging
- SCOPE 2023 Conference Preview
- SCOPE Europe 2023: 5 Unmissable Sessions and Insights for Clinical Operations Professionals
- SCOPE Orlando 2024: The Summit for Clinical Ops Executives
- Social Media for Clinical Trial Recruitment
- Streamlining KOL Identification: 3 Tips for Medical Affairs Teams
- Support for Awareness Campaigns: Good for Pharma and Patients
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
- Tech Skills and Digital Natives in Demand as Clinical Trial Industry Evolves
- The Benefits of Big Data in Drug Development
- The Benefits of Standardized, Machine-Readable Clinical Data
- The Continuing Rise of Decentralized Clinical Trials
- The Emerging Role of Medical Science Liaisons on Medical Affairs Teams
- The FDA Race and Ethnicity Diversity Plan: How to Get Researchers Prepared
- The FDA’s Newest Guidance on Decentralized Trials: 5 Things to Know
- The Future of Decentralized Trials
- The Importance of Diversity in Clinical Trials: A Comprehensive Analysis
- The Importance of User Experience in Life Sciences Software
- The Mental Health Impact of COVID-19 And How MA Teams Can Help
- The Next Step: Using AI to Formulate Clinical Trial Research Questions
- The Post-Pandemic Future of Medical Information Call Centers
- The Present and Future of Synthetic Data
- The Regulations Clinical Researchers Should Track in 2024
- The Requirements of an Effective Electronic Data Capture System (EDCS)
- The Right Tool for EDC
- The Role of Electronic Data Capture in Decentralized Trials
- The Role of Medical Affairs in Combating Misinformation
- The Role of Nurse Navigators in Oncology Trials
- The Role of Site Selection in Promoting Health Equity
- The State of Clinical Research During the COVID-19 Pandemic
- The Transformative Role of Generative AI in Regulatory Compliance and MA Communications
- The Ugly Truth About Paper Diaries
- Three Ways Decentralized Trials Bolster Patient Recruitment
- Time for Clinical Trials to Deliver on Patient-Centric Care Promises
- Top 2020 Conferences CROs Should Not Miss
- Top KPIs for Measuring Medical Affairs Success in 2022
- Tracking Relationships: Understanding KPIs That Measure KOL Engagement
- Trial Eligibility Criteria: The Problem with Current Exclusion Strategies
- TrialMaster: The Right EDC Solution For Oncology Trials [White Paper]
- Trust-building in a Pandemic: Collaborative Strategies for MA teams
- Uncovering Predatory Journals and Conferences: Best Practices
- Understanding Attrition: Gleaning Insights From Patients Who Quit
- Understanding Cross-Border Enrollment for International Clinical Trials
- Understanding FDA 483: How To Run a Compliant Trial Every Time
- Understanding HHS’ Proposed Rule Changes to HIPAA
- Understanding Risk-Based Clinical Quality Management Technology
- Understanding Roles and Needs of Stakeholders in Decentralized Trials
- Understanding Security and Role-Based Access in an eTMF Platform
- Understanding the Changing Face of Early Phase Clinical Trials
- Understanding the Value of Blockchain for Clinical Trial Data
- Understanding Which KOLs are Key for You
- Unified Data Platform’s Impact on Clinical Trial Procedures
- Updated FDA Race and Diversity Guidance Open for Comments
- Using AI to Formulate Clinical Trial Research Questions
- Video Interview: Advancing Clinical Trials with Advanced Technology
- Virtual Reality in Clinical Research: Potential and Challenges
- Voice Tech and Wearables’ Emerging Role in Clinical Trials
- What Are The Responsibilities of a Clinical Data Manager and How Have They Evolved?
- What Challenges Face Researchers With Direct-To-Patient Trials
- What Extra Support Should Clinical Research Teams Offer Participants?
- What Five Key Features Should a Trial Director Look for in an EDC?
- What Google’s Entrance Into Healthcare Data Means for Clinical Trials
- What Happens When Medical Affairs Intersects with Politics?
- What is the Role of Synthetic Data in Early-Phase Clinical Trials?
- What to Consider When Adopting New Technology in Clinical Trials
- What To Look For in an eTMF
- When a Direct-to-Patient Trial Model Is the Right Choice
- Why an eTMF? It’s Time for a Specialized Digital Solution
- Why CRO Staff Need Robust Digital Literacy Skills
- Why Life Sciences Companies Need Regular Medical Affairs Audits
- Why Medical Affairs Must Lead a Patient-Centric Approach to R&D
- Why Time Management is Essential for Clinical Trials
- Why Your eTMF Needs Role-Based Access
- Women’s Representation in Clinical Trials: Beyond Equality
- Working With Disparate Data Sources To Improve Your Trials
- World-Class EDC for World-Class Cancer Research Center
- You’ve Collected Your Medical Affairs Data. Now What?
Interview
- Anju’s Adaptive Tech Solutions for Clinical Trials and Medical Affairs
- Anju’s Growth Strategy: CEO’s Perspective
- COVID-19’s Transformation of the Clinical Trial Industry Ecosystem
- dTrial Forum in Nanjing, China hosts Feng Cheng as speaker
- Global Oncology Community Leveraging Technology for Clinical Trials
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Video Interview: Advancing Clinical Trials with Advanced Technology
KOL
- 5 Strategies to Engage Digital Opinion Leaders
- Building Opinion Leader Relationships in a Post-Pandemic World
- Digital Opinion Leaders in Post-COVID Medical Affairs
- How Medical Science Liaisons Should Engage With Key Opinion Leaders
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Machine Learning and KOL Networks: The Future of Medical Affairs
- Medical Affairs KPIs: How to Create a Framework For Measuring Success
- Streamlining KOL Identification: 3 Tips for Medical Affairs Teams
- Tracking Relationships: Understanding KPIs That Measure KOL Engagement
- Understanding Which KOLs are Key for You
Medical Affairs
- 10 Global Medical Affairs Conferences to Attend in 2020
- 10 Medical Affairs Conferences in Late 2020 and Early 2021
- 17th Annual Meeting of ISMPP 2021
- 2019 European Meeting of ISMPP
- 2020 European Meeting of ISMPP: Achieving Clarity, Reach and Value
- 4 Ways an IRMS Helps Medical Affairs Manage and Share Insights
- 5 Strategies to Engage Digital Opinion Leaders
- 5 Things Medical Affairs Can Do to Support Late Life Cycle Drugs
- AI and Clinical Intelligence in Oncology Research
- Anju Discusses COVID Impact on Call Center at DIA
- Anju Leads Virtual Medical Content Compliance at TIPPA
- Anju Proudly Sponsors DIA MASC 2021 Forum
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- Anju to Exhibit at MAPS 2024 in Puerto Rico
- Best Practices of Medical Affairs Publication Planning in 2021
- Building a Strong Foundation for Medical Affairs Leadership
- Building Opinion Leader Relationships in a Post-Pandemic World
- CBI Medical Publications & Communications Forum – Anju
- CBI’s Medical Publications Forum Insights
- Choosing a Medical Affairs CRM Platform: Key Considerations
- Clinical Trial & Therapy Results: Anju’s Pubstrat MAX
- Clinical Trial Data Sharing: Medical Affairs’ Role
- Collaboration Opportunities Between Regulators and Medical Affairs
- Come visit us at the TIPPA Conference in San Diego
- COVID-19 Vaccine’s Impact on the Role of Medical Affairs
- COVID: The Role of Medical Affairs Teams in Public Health
- Data Protection in Medical Affairs: Basic Cybersecurity
- Deeper KOL Connections: How Information Design Empowers Medical Affairs
- DIA 12th Annual European Medical Information Conference
- DIA Medical Information and Communications Conference
- Digital Opinion Leaders in Post-COVID Medical Affairs
- Drug Labeling Trends: Making Language Accessible to Patients
- Explore Anju’s AI Roadmap at the 20th Annual Meeting of ISMPP
- How Big Data and AI Are Changing the Role of Medical Affairs
- How Big Data and AI Are Changing the Role of Medical Affairs & Pharma
- How Medical Affairs Can Amplify the Patient Voice
- How Medical Affairs Can Support a Product Against New Competition
- How Medical Affairs Can Support Pharma Marketing
- How Medical Affairs Can Use Tech to Provide Medical Information Letters
- How Medical Affairs Teams Can Advocate for Patient-Centric Healthcare
- How Medical Affairs Teams Can Boost Stakeholder Engagement
- How Medical Affairs Teams Can Help Get Off-Label Drugs to Patients
- How Medical Affairs Teams Can Improve Their Digital Communications
- How Medical Affairs Teams Can Optimize Product Life Cycle
- How Medical Science Liaisons Should Engage With Key Opinion Leaders
- How MSLs Became Pharma’s Essential Information Contact Point
- How Patient Voices Power Pharmaceutical Innovation
- How To Empower Medical Science Liaisons With Data, and Why You Should
- How to Measure the Effectiveness of Medical Information Distribution
- Impact of Cybersecurity and Data Privacy on Medical Affairs Teams
- INSIGHTS from DIA 2019 MICC
- Is Lack of Data Integration Undermining Your Medical Affairs Efforts?
- ISMPP EU Virtual Conference 2021
- ISMPP West 2019: Changing Tides in Scientific Communications
- ISMPP West 2021: Opportunities for Connectivity
- Join Anju at Pharma Europe 2021: MSL Empowerment Talk
- Join ISMPP in Sunny San Diego for Historic Meeting
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Machine Learning and KOL Networks: The Future of Medical Affairs
- Maintain Remote Professional Relationships: 3 Tips for Medical Affairs
- MAPS Annual Meeting 2019 – Not just a one-time event…
- MASS West 2019 – Medical Affairs Strategic Summit
- Medical Affairs KPIs: How to Create a Framework For Measuring Success
- Medical Affairs Leads COVID-19 Response
- Medical Affairs Provides Credible Consumer Information
- Medical Information Management: Balancing Security With Accessibility
- Medical Publishing: How the Right Tools Maximize Your Deliverable’s Reach
- Meet Us at 15th Annual ISMPP Meeting, National Harbor
- New Shifts In The Medical Affairs Ecosystem
- Notable Speakers: DIA Medical Information Conference
- Optimizing Outreach: Effective Communication Strategies for Medical Affairs Teams in 2024
- Pandemic-Driven Medical Affairs and Scientific Insights Management
- Promoting Value-Based Clinical Trials in Medical Affairs
- Public Health Misinformation: What Can Medical Affairs Teams Do?
- Publicizing Research: Reach Audiences and Combat Misinformation
- Researchers Whose Work May Lead to Cancer Treatment Breakthroughs
- Science Behind the Comms: How MA Teams Add Value to Messaging
- Streamlining KOL Identification: 3 Tips for Medical Affairs Teams
- TA Scan Won SCOPE Best of Show Award
- The Emerging Role of Medical Science Liaisons on Medical Affairs Teams
- The Mental Health Impact of COVID-19 And How MA Teams Can Help
- The Post-Pandemic Future of Medical Information Call Centers
- The Role of Medical Affairs in Combating Misinformation
- The Transformative Role of Generative AI in Regulatory Compliance and MA Communications
- Top KPIs for Measuring Medical Affairs Success in 2022
- Tracking Relationships: Understanding KPIs That Measure KOL Engagement
- Trust-building in a Pandemic: Collaborative Strategies for MA teams
- Uncovering Predatory Journals and Conferences: Best Practices
- Understanding Which KOLs are Key for You
- What Happens When Medical Affairs Intersects with Politics?
- Why Life Sciences Companies Need Regular Medical Affairs Audits
- Why Medical Affairs Must Lead a Patient-Centric Approach to R&D
- You’ve Collected Your Medical Affairs Data. Now What?
Medical Affairs
- 10 Global Medical Affairs Conferences to Attend in 2020
- 10 Medical Affairs Conferences in Late 2020 and Early 2021
- 4 Ways an IRMS Helps Medical Affairs Manage and Share Insights
- 5 Strategies to Engage Digital Opinion Leaders
- 5 Things Medical Affairs Can Do to Support Late Life Cycle Drugs
- AI and Clinical Intelligence in Oncology Research
- Anju Acquires Online Business Apps
- Anju Acquires Sylogent for Publication Planning
- Anju Elevates Agency Support with PUBSTRAT Software Suite
- Anju Launches Safe ECM for Life Sciences
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- Anju Software Welcomes Natera to Its PUBSTRAT Partner Community
- Anju to Exhibit at MAPS 2024 in Puerto Rico
- Anju to Showcase Industry-Leading Publication Planning Solution at ISMPP Europe 2024
- Anju’s ECM Tested for Global Scalability
- Anju’s IRMS Enhances Efficiency with Self-Service Portal
- Anju’s Self-Service Portal Cuts MedInfo Costs, Boosts HCP Satisfaction
- Best Practices of Medical Affairs Publication Planning in 2021
- Building a Strong Foundation for Medical Affairs Leadership
- Building Opinion Leader Relationships in a Post-Pandemic World
- CBI’s Medical Publications Forum Insights
- Choosing a Medical Affairs CRM Platform: Key Considerations
- Clinical Trial & Therapy Results: Anju’s Pubstrat MAX
- Clinical Trial Data Sharing: Medical Affairs’ Role
- Collaboration Opportunities Between Regulators and Medical Affairs
- COVID-19 Vaccine’s Impact on the Role of Medical Affairs
- COVID: The Role of Medical Affairs Teams in Public Health
- Data Protection in Medical Affairs: Basic Cybersecurity
- Deeper KOL Connections: How Information Design Empowers Medical Affairs
- Digital Opinion Leaders in Post-COVID Medical Affairs
- Drug Labeling Trends: Making Language Accessible to Patients
- Explore Anju’s AI Roadmap at the 20th Annual Meeting of ISMPP
- How Big Data and AI Are Changing the Role of Medical Affairs & Pharma
- How Medical Affairs Can Amplify the Patient Voice
- How Medical Affairs Can Support a Product Against New Competition
- How Medical Affairs Can Support Pharma Marketing
- How Medical Affairs Can Use Tech to Provide Medical Information Letters
- How Medical Affairs Teams Can Advocate for Patient-Centric Healthcare
- How Medical Affairs Teams Can Boost Stakeholder Engagement
- How Medical Affairs Teams Can Help Get Off-Label Drugs to Patients
- How Medical Affairs Teams Can Improve Their Digital Communications
- How Medical Affairs Teams Can Optimize Product Life Cycle
- How Medical Science Liaisons Should Engage With Key Opinion Leaders
- How MSLs Became Pharma’s Essential Information Contact Point
- How Patient Voices Power Pharmaceutical Innovation
- How To Empower Medical Science Liaisons With Data, and Why You Should
- How to Measure the Effectiveness of Medical Information Distribution
- Impact of Cybersecurity and Data Privacy on Medical Affairs Teams
- INSIGHTS from DIA 2019 MICC
- Is Lack of Data Integration Undermining Your Medical Affairs Efforts?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Machine Learning and KOL Networks: The Future of Medical Affairs
- Maintain Remote Professional Relationships: 3 Tips for Medical Affairs
- Medical Affairs KPIs: How to Create a Framework For Measuring Success
- Medical Affairs Leads COVID-19 Response
- Medical Affairs Provides Credible Consumer Information
- Medical Information Management: Balancing Security With Accessibility
- Medical Publishing: How the Right Tools Maximize Your Deliverable’s Reach
- New Shifts In The Medical Affairs Ecosystem
- Optimizing Outreach: Effective Communication Strategies for Medical Affairs Teams in 2024
- Pandemic-Driven Medical Affairs and Scientific Insights Management
- Pharma Company Enhances Med Affairs Communication with Anju
- Promoting Value-Based Clinical Trials in Medical Affairs
- Public Health Misinformation: What Can Medical Affairs Teams Do?
- Publicizing Research: Reach Audiences and Combat Misinformation
- PUBSTRAT MAX: Anju’s Innovative Publication Management
- PUBSTRAT’s 2019 Resurgence: Innovation & Service-Driven
- Researchers Whose Work May Lead to Cancer Treatment Breakthroughs
- Science Behind the Comms: How MA Teams Add Value to Messaging
- Streamlining KOL Identification: 3 Tips for Medical Affairs Teams
- TA Scan Won SCOPE Best of Show Award
- The Emerging Role of Medical Science Liaisons on Medical Affairs Teams
- The Mental Health Impact of COVID-19 And How MA Teams Can Help
- The Post-Pandemic Future of Medical Information Call Centers
- The Role of Medical Affairs in Combating Misinformation
- The Transformative Role of Generative AI in Regulatory Compliance and MA Communications
- Top KPIs for Measuring Medical Affairs Success in 2022
- Tracking Relationships: Understanding KPIs That Measure KOL Engagement
- Trust-building in a Pandemic: Collaborative Strategies for MA teams
- Uncovering Predatory Journals and Conferences: Best Practices
- Understanding Which KOLs are Key for You
- What Happens When Medical Affairs Intersects with Politics?
- Why Life Sciences Companies Need Regular Medical Affairs Audits
- Why Medical Affairs Must Lead a Patient-Centric Approach to R&D
- You’ve Collected Your Medical Affairs Data. Now What?
Medical Affairs
- 10 Global Medical Affairs Conferences to Attend in 2020
- 10 Medical Affairs Conferences in Late 2020 and Early 2021
- 4 Ways an IRMS Helps Medical Affairs Manage and Share Insights
- 5 Strategies to Engage Digital Opinion Leaders
- 5 Things Medical Affairs Can Do to Support Late Life Cycle Drugs
- AI and Clinical Intelligence in Oncology Research
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- Anju to Exhibit at MAPS 2024 in Puerto Rico
- Best Practices of Medical Affairs Publication Planning in 2021
- Building a Strong Foundation for Medical Affairs Leadership
- Building Opinion Leader Relationships in a Post-Pandemic World
- CBI’s Medical Publications Forum Insights
- Choosing a Medical Affairs CRM Platform: Key Considerations
- Clinical Trial & Therapy Results: Anju’s Pubstrat MAX
- Clinical Trial Data Sharing: Medical Affairs’ Role
- Collaboration Opportunities Between Regulators and Medical Affairs
- COVID-19 Vaccine’s Impact on the Role of Medical Affairs
- COVID: The Role of Medical Affairs Teams in Public Health
- Data Protection in Medical Affairs: Basic Cybersecurity
- Deeper KOL Connections: How Information Design Empowers Medical Affairs
- Digital Opinion Leaders in Post-COVID Medical Affairs
- Drug Labeling Trends: Making Language Accessible to Patients
- Explore Anju’s AI Roadmap at the 20th Annual Meeting of ISMPP
- How Big Data and AI Are Changing the Role of Medical Affairs & Pharma
- How Medical Affairs Can Amplify the Patient Voice
- How Medical Affairs Can Support a Product Against New Competition
- How Medical Affairs Can Support Pharma Marketing
- How Medical Affairs Can Use Tech to Provide Medical Information Letters
- How Medical Affairs Teams Can Advocate for Patient-Centric Healthcare
- How Medical Affairs Teams Can Boost Stakeholder Engagement
- How Medical Affairs Teams Can Help Get Off-Label Drugs to Patients
- How Medical Affairs Teams Can Improve Their Digital Communications
- How Medical Affairs Teams Can Optimize Product Life Cycle
- How Medical Science Liaisons Should Engage With Key Opinion Leaders
- How MSLs Became Pharma’s Essential Information Contact Point
- How Patient Voices Power Pharmaceutical Innovation
- How To Empower Medical Science Liaisons With Data, and Why You Should
- How to Measure the Effectiveness of Medical Information Distribution
- Impact of Cybersecurity and Data Privacy on Medical Affairs Teams
- INSIGHTS from DIA 2019 MICC
- Is Lack of Data Integration Undermining Your Medical Affairs Efforts?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Machine Learning and KOL Networks: The Future of Medical Affairs
- Maintain Remote Professional Relationships: 3 Tips for Medical Affairs
- Medical Affairs KPIs: How to Create a Framework For Measuring Success
- Medical Affairs Leads COVID-19 Response
- Medical Affairs Provides Credible Consumer Information
- Medical Information Management: Balancing Security With Accessibility
- Medical Publishing: How the Right Tools Maximize Your Deliverable’s Reach
- New Shifts In The Medical Affairs Ecosystem
- Optimizing Outreach: Effective Communication Strategies for Medical Affairs Teams in 2024
- Pandemic-Driven Medical Affairs and Scientific Insights Management
- Promoting Value-Based Clinical Trials in Medical Affairs
- Public Health Misinformation: What Can Medical Affairs Teams Do?
- Publicizing Research: Reach Audiences and Combat Misinformation
- Researchers Whose Work May Lead to Cancer Treatment Breakthroughs
- Science Behind the Comms: How MA Teams Add Value to Messaging
- Streamlining KOL Identification: 3 Tips for Medical Affairs Teams
- TA Scan Won SCOPE Best of Show Award
- The Emerging Role of Medical Science Liaisons on Medical Affairs Teams
- The Mental Health Impact of COVID-19 And How MA Teams Can Help
- The Post-Pandemic Future of Medical Information Call Centers
- The Role of Medical Affairs in Combating Misinformation
- The Transformative Role of Generative AI in Regulatory Compliance and MA Communications
- Top KPIs for Measuring Medical Affairs Success in 2022
- Tracking Relationships: Understanding KPIs That Measure KOL Engagement
- Trust-building in a Pandemic: Collaborative Strategies for MA teams
- Uncovering Predatory Journals and Conferences: Best Practices
- Understanding Which KOLs are Key for You
- Webinar – IRMS Classic to Web Upgrade Advantage
- What Happens When Medical Affairs Intersects with Politics?
- Why Life Sciences Companies Need Regular Medical Affairs Audits
- Why Medical Affairs Must Lead a Patient-Centric Approach to R&D
- You’ve Collected Your Medical Affairs Data. Now What?
Medical Affairs
- 10 Global Medical Affairs Conferences to Attend in 2020
- 10 Medical Affairs Conferences in Late 2020 and Early 2021
- 4 Ways an IRMS Helps Medical Affairs Manage and Share Insights
- 5 Strategies to Engage Digital Opinion Leaders
- 5 Things Medical Affairs Can Do to Support Late Life Cycle Drugs
- AI and Clinical Intelligence in Oncology Research
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- Anju to Exhibit at MAPS 2024 in Puerto Rico
- Best Practices of Medical Affairs Publication Planning in 2021
- Building a Strong Foundation for Medical Affairs Leadership
- Building Opinion Leader Relationships in a Post-Pandemic World
- CBI’s Medical Publications Forum Insights
- Choosing a Medical Affairs CRM Platform: Key Considerations
- Clinical Trial & Therapy Results: Anju’s Pubstrat MAX
- Clinical Trial Data Sharing: Medical Affairs’ Role
- Collaboration Opportunities Between Regulators and Medical Affairs
- COVID-19 Vaccine’s Impact on the Role of Medical Affairs
- COVID: The Role of Medical Affairs Teams in Public Health
- Data Protection in Medical Affairs: Basic Cybersecurity
- Deeper KOL Connections: How Information Design Empowers Medical Affairs
- Digital Opinion Leaders in Post-COVID Medical Affairs
- Drug Labeling Trends: Making Language Accessible to Patients
- Explore Anju’s AI Roadmap at the 20th Annual Meeting of ISMPP
- How Big Data and AI Are Changing the Role of Medical Affairs & Pharma
- How Medical Affairs Can Amplify the Patient Voice
- How Medical Affairs Can Support a Product Against New Competition
- How Medical Affairs Can Support Pharma Marketing
- How Medical Affairs Can Use Tech to Provide Medical Information Letters
- How Medical Affairs Teams Can Advocate for Patient-Centric Healthcare
- How Medical Affairs Teams Can Boost Stakeholder Engagement
- How Medical Affairs Teams Can Help Get Off-Label Drugs to Patients
- How Medical Affairs Teams Can Improve Their Digital Communications
- How Medical Affairs Teams Can Optimize Product Life Cycle
- How Medical Science Liaisons Should Engage With Key Opinion Leaders
- How MSLs Became Pharma’s Essential Information Contact Point
- How Patient Voices Power Pharmaceutical Innovation
- How To Empower Medical Science Liaisons With Data, and Why You Should
- How to Measure the Effectiveness of Medical Information Distribution
- Impact of Cybersecurity and Data Privacy on Medical Affairs Teams
- INSIGHTS from DIA 2019 MICC
- Is Lack of Data Integration Undermining Your Medical Affairs Efforts?
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Machine Learning and KOL Networks: The Future of Medical Affairs
- Maintain Remote Professional Relationships: 3 Tips for Medical Affairs
- Medical Affairs KPIs: How to Create a Framework For Measuring Success
- Medical Affairs Leads COVID-19 Response
- Medical Affairs Provides Credible Consumer Information
- Medical Information Management: Balancing Security With Accessibility
- Medical Publishing: How the Right Tools Maximize Your Deliverable’s Reach
- New Shifts In The Medical Affairs Ecosystem
- Optimizing Outreach: Effective Communication Strategies for Medical Affairs Teams in 2024
- Pandemic-Driven Medical Affairs and Scientific Insights Management
- Promoting Value-Based Clinical Trials in Medical Affairs
- Public Health Misinformation: What Can Medical Affairs Teams Do?
- Publicizing Research: Reach Audiences and Combat Misinformation
- Researchers Whose Work May Lead to Cancer Treatment Breakthroughs
- Science Behind the Comms: How MA Teams Add Value to Messaging
- Streamlining KOL Identification: 3 Tips for Medical Affairs Teams
- TA Scan Won SCOPE Best of Show Award
- The Emerging Role of Medical Science Liaisons on Medical Affairs Teams
- The Mental Health Impact of COVID-19 And How MA Teams Can Help
- The Post-Pandemic Future of Medical Information Call Centers
- The Role of Medical Affairs in Combating Misinformation
- The Transformative Role of Generative AI in Regulatory Compliance and MA Communications
- Top KPIs for Measuring Medical Affairs Success in 2022
- Tracking Relationships: Understanding KPIs That Measure KOL Engagement
- Trust-building in a Pandemic: Collaborative Strategies for MA teams
- Uncovering Predatory Journals and Conferences: Best Practices
- Understanding Which KOLs are Key for You
- What Happens When Medical Affairs Intersects with Politics?
- Why Life Sciences Companies Need Regular Medical Affairs Audits
- Why Medical Affairs Must Lead a Patient-Centric Approach to R&D
- You’ve Collected Your Medical Affairs Data. Now What?
Medical Information
- 4 Ways an IRMS Helps Medical Affairs Manage and Share Insights
- 5 Things Medical Affairs Can Do to Support Late Life Cycle Drugs
- Anju Discusses COVID Impact on Call Center at DIA
- Anju Proudly Sponsors DIA MASC 2021 Forum
- Data Protection in Medical Affairs: Basic Cybersecurity
- DIA 12th Annual European Medical Information Conference
- DIA Medical Information and Communications Conference
- Drug Labeling Trends: Making Language Accessible to Patients
- How Big Data and AI Are Changing the Role of Medical Affairs
- How Medical Affairs Can Support a Product Against New Competition
- How Medical Affairs Can Use Tech to Provide Medical Information Letters
- How Medical Affairs Teams Can Help Get Off-Label Drugs to Patients
- How Medical Affairs Teams Can Improve Their Digital Communications
- How Medical Affairs Teams Can Optimize Product Life Cycle
- How to Measure the Effectiveness of Medical Information Distribution
- INSIGHTS from DIA 2019 MICC
- Laurence Birch Interview: Adaptive Life Sciences Tech
- MASS West 2019 – Medical Affairs Strategic Summit
- Medical Affairs Provides Credible Consumer Information
- New Shifts In The Medical Affairs Ecosystem
- Notable Speakers: DIA Medical Information Conference
- The Post-Pandemic Future of Medical Information Call Centers
- The Role of Medical Affairs in Combating Misinformation
Medical Information
- 4 Ways an IRMS Helps Medical Affairs Manage and Share Insights
- 5 Things Medical Affairs Can Do to Support Late Life Cycle Drugs
- Data Protection in Medical Affairs: Basic Cybersecurity
- Drug Labeling Trends: Making Language Accessible to Patients
- How Medical Affairs Can Support a Product Against New Competition
- How Medical Affairs Can Use Tech to Provide Medical Information Letters
- How Medical Affairs Teams Can Help Get Off-Label Drugs to Patients
- How Medical Affairs Teams Can Improve Their Digital Communications
- How Medical Affairs Teams Can Optimize Product Life Cycle
- How to Measure the Effectiveness of Medical Information Distribution
- INSIGHTS from DIA 2019 MICC
- IRTMaster by OmniComm: Accelerating Trial Development
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Medical Affairs Provides Credible Consumer Information
- New Shifts In The Medical Affairs Ecosystem
- The Post-Pandemic Future of Medical Information Call Centers
- The Role of Medical Affairs in Combating Misinformation
Medical Information
- 4 Ways an IRMS Helps Medical Affairs Manage and Share Insights
- 5 Things Medical Affairs Can Do to Support Late Life Cycle Drugs
- Anju Acquires Online Business Apps
- Anju Launches Safe ECM for Life Sciences
- Anju’s IRMS Enhances Efficiency with Self-Service Portal
- Anju’s Self-Service Portal Cuts MedInfo Costs, Boosts HCP Satisfaction
- Data Protection in Medical Affairs: Basic Cybersecurity
- Drug Labeling Trends: Making Language Accessible to Patients
- How Medical Affairs Can Support a Product Against New Competition
- How Medical Affairs Can Use Tech to Provide Medical Information Letters
- How Medical Affairs Teams Can Help Get Off-Label Drugs to Patients
- How Medical Affairs Teams Can Improve Their Digital Communications
- How Medical Affairs Teams Can Optimize Product Life Cycle
- How to Measure the Effectiveness of Medical Information Distribution
- INSIGHTS from DIA 2019 MICC
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Medical Affairs Provides Credible Consumer Information
- New Shifts In The Medical Affairs Ecosystem
- Pharma Company Enhances Med Affairs Communication with Anju
- The Post-Pandemic Future of Medical Information Call Centers
- The Role of Medical Affairs in Combating Misinformation
Medical Information
- 4 Ways an IRMS Helps Medical Affairs Manage and Share Insights
- 5 Things Medical Affairs Can Do to Support Late Life Cycle Drugs
- Data Protection in Medical Affairs: Basic Cybersecurity
- Drug Labeling Trends: Making Language Accessible to Patients
- How Medical Affairs Can Support a Product Against New Competition
- How Medical Affairs Can Use Tech to Provide Medical Information Letters
- How Medical Affairs Teams Can Help Get Off-Label Drugs to Patients
- How Medical Affairs Teams Can Improve Their Digital Communications
- How Medical Affairs Teams Can Optimize Product Life Cycle
- How to Measure the Effectiveness of Medical Information Distribution
- INSIGHTS from DIA 2019 MICC
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Medical Affairs Provides Credible Consumer Information
- New Shifts In The Medical Affairs Ecosystem
- The Post-Pandemic Future of Medical Information Call Centers
- The Role of Medical Affairs in Combating Misinformation
- Webinar – IRMS Classic to Web Upgrade Advantage
Medical Information
- 4 Ways an IRMS Helps Medical Affairs Manage and Share Insights
- 5 Things Medical Affairs Can Do to Support Late Life Cycle Drugs
- Data Protection in Medical Affairs: Basic Cybersecurity
- Drug Labeling Trends: Making Language Accessible to Patients
- How Medical Affairs Can Support a Product Against New Competition
- How Medical Affairs Can Use Tech to Provide Medical Information Letters
- How Medical Affairs Teams Can Help Get Off-Label Drugs to Patients
- How Medical Affairs Teams Can Improve Their Digital Communications
- How Medical Affairs Teams Can Optimize Product Life Cycle
- How to Measure the Effectiveness of Medical Information Distribution
- INSIGHTS from DIA 2019 MICC
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Medical Affairs Provides Credible Consumer Information
- New Shifts In The Medical Affairs Ecosystem
- The Post-Pandemic Future of Medical Information Call Centers
- The Role of Medical Affairs in Combating Misinformation
MSL
- Choosing a Medical Affairs CRM Platform: Key Considerations
- How Medical Science Liaisons Should Engage With Key Opinion Leaders
- How To Empower Medical Science Liaisons With Data, and Why You Should
- Join Anju at Pharma Europe 2021: MSL Empowerment Talk
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Medical Affairs KPIs: How to Create a Framework For Measuring Success
- The Emerging Role of Medical Science Liaisons on Medical Affairs Teams
MSL
- Choosing a Medical Affairs CRM Platform: Key Considerations
- How Medical Science Liaisons Should Engage With Key Opinion Leaders
- How To Empower Medical Science Liaisons With Data, and Why You Should
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Medical Affairs KPIs: How to Create a Framework For Measuring Success
- The Emerging Role of Medical Science Liaisons on Medical Affairs Teams
Patient Engagement
- Benefits and Challenges in Virtual Clinical Trials
- Bias in Clinical Trial Incentives
- Clinical Research as Care Option for Better Outcomes
- Clinical Trial Under-Enrollment: How to Prevent It
- Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
- Does Your Clinical Trial Need a Chief Patient Experience Officer?
- Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop
- Enhancing Virtual Bedside Manner in Clinical Trials
- Global Clinical Trials: Managing Patients and Meeting Compliance
- How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?
- How Does Greater Patient Control of Healthcare Data Impact Clinical Trials?
- How to Create Social Media Content to Engage Clinical Trials Patients
- How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them
- How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
- How to Improve Patient Retention in Clinical Trials
- How to Manage Patient Fear Regarding Clinical Trial Risks
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Lightening the Load: Reducing Patient Burden in Clinical Trials
- Partnering with Patient Advocacy Groups Benefits Pharma and Patients
- Patient-Centric Approach in Clinical Trial Design: Involve Patients Early
- Patients as Partners: The Value of Post-Trial Communication
- Rare Disease Clinical Trials: How to Improve Participation and Outcomes
- Retaining Trial Participants: Adherence and Dropout Mitigation
- SCOPE 2023 Conference Preview
- Support for Awareness Campaigns: Good for Pharma and Patients
- The Role of Nurse Navigators in Oncology Trials
- Three Ways Decentralized Trials Bolster Patient Recruitment
- Understanding Attrition: Gleaning Insights From Patients Who Quit
- What Extra Support Should Clinical Research Teams Offer Participants?
Patient Engagement
- Benefits and Challenges in Virtual Clinical Trials
- Bias in Clinical Trial Incentives
- Clinical Research as Care Option for Better Outcomes
- Clinical Trial Under-Enrollment: How to Prevent It
- Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
- Does Your Clinical Trial Need a Chief Patient Experience Officer?
- Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop
- Enhancing Virtual Bedside Manner in Clinical Trials
- Global Clinical Trials: Managing Patients and Meeting Compliance
- How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?
- How to Create Social Media Content to Engage Clinical Trials Patients
- How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them
- How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
- How to Improve Patient Retention in Clinical Trials
- How to Manage Patient Fear Regarding Clinical Trial Risks
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Lightening the Load: Reducing Patient Burden in Clinical Trials
- Partnering with Patient Advocacy Groups Benefits Pharma and Patients
- Patient-Centric Approach in Clinical Trial Design: Involve Patients Early
- Patients as Partners: The Value of Post-Trial Communication
- Rare Disease Clinical Trials: How to Improve Participation and Outcomes
- Retaining Trial Participants: Adherence and Dropout Mitigation
- SCOPE 2023 Conference Preview
- Support for Awareness Campaigns: Good for Pharma and Patients
- The Role of Nurse Navigators in Oncology Trials
- Three Ways Decentralized Trials Bolster Patient Recruitment
- Understanding Attrition: Gleaning Insights From Patients Who Quit
- What Extra Support Should Clinical Research Teams Offer Participants?
Patient Engagement
- Benefits and Challenges in Virtual Clinical Trials
- Bias in Clinical Trial Incentives
- Clinical Research as Care Option for Better Outcomes
- Clinical Trial Under-Enrollment: How to Prevent It
- Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
- Does Your Clinical Trial Need a Chief Patient Experience Officer?
- Engagement and Adherence: How Technology is Keeping Trial Patients in the Loop
- Enhancing Virtual Bedside Manner in Clinical Trials
- Global Clinical Trials: Managing Patients and Meeting Compliance
- How Do Clinical Trial Recruitment Incentives Bias Research Outcomes?
- How Medical Affairs Can Support Pharma Marketing
- How Patient Voices Power Pharmaceutical Innovation
- How to Create Social Media Content to Engage Clinical Trials Patients
- How to Engage Primary Care Providers in Clinical Trials and Connect With Patients Who Don’t Have Them
- How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
- How to Improve Patient Retention in Clinical Trials
- How to Manage Patient Fear Regarding Clinical Trial Risks
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Lightening the Load: Reducing Patient Burden in Clinical Trials
- Partnering with Patient Advocacy Groups Benefits Pharma and Patients
- Patient-Centric Approach in Clinical Trial Design: Involve Patients Early
- Patients as Partners: The Value of Post-Trial Communication
- Rare Disease Clinical Trials: How to Improve Participation and Outcomes
- Retaining Trial Participants: Adherence and Dropout Mitigation
- SCOPE 2023 Conference Preview
- Support for Awareness Campaigns: Good for Pharma and Patients
- TA Scan Won SCOPE Best of Show Award
- The Role of Nurse Navigators in Oncology Trials
- Three Ways Decentralized Trials Bolster Patient Recruitment
- Understanding Attrition: Gleaning Insights From Patients Who Quit
- What Extra Support Should Clinical Research Teams Offer Participants?
Press Release
- Anju Acquires Online Business Apps
- Anju Acquires Sylogent for Publication Planning
- Anju Acquires Zephyr Health
- Anju Advances Life Science Software and Data Through Acquisition of MDCPartners
- Anju Appoints Laurence Birch as Chief Executive Officer
- Anju Boosts Life Science Portfolio with OpenQ Acquisition
- Anju CEO Laurence Birch on Price of Business Show
- Anju Completes Merger with OmniComm Systems
- Anju Elevates Agency Support with PUBSTRAT Software Suite
- Anju Enters Clinical Trial Software: ClinPlus Acquisition
- Anju Expands Clinical Research Data Site & Investigator Optimization Offering
- Anju Expands ta-Scan Offering
- Anju Featured in CIO Review
- Anju Introduces eTMF Master for Electronic Trial Master File Management
- Anju Introduces RTSM Randomization Simulator
- Anju Launches Life Sciences Big Data Management Platform
- Anju Launches New CRO Partner Program
- Anju Launches Safe ECM for Life Sciences
- Anju Recognized in Gartner’s 2021 Hype Cycle
- Anju Showcases Life Science Solutions at SCDM
- Anju Software Launches a Web-based Coding System
- Anju Software Recapitalizes with Abry Partners
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- Anju Software Welcomes Natera to Its PUBSTRAT Partner Community
- Anju to Exhibit and Present at EUCROF24: Leveraging Data for Enhanced Site Selection and Feasibility in Clinical Trials
- Anju to Exhibit at MAPS 2024 in Puerto Rico
- Anju to Showcase Industry-Leading Publication Planning Solution at ISMPP Europe 2024
- Anju Welcomes Atherion Bioresearch as the Newest CRO Partner
- Anju’s ECM Tested for Global Scalability
- Anju’s IRMS Enhances Efficiency with Self-Service Portal
- Anju’s Presence at DIA 2023 Global Annual Meeting
- Anju’s Rapid COVID Study Build in 10 Days with eClinical Suite
- Anju’s Self-Service Portal Cuts MedInfo Costs, Boosts HCP Satisfaction
- ClinChoice & Anju Partner: Life Science Information Management
- Explore Anju’s AI Roadmap at the 20th Annual Meeting of ISMPP
- FGK Clinical Research Signs Five-Year Agreement with OmniComm
- Global Diversity Data with TA Scan at SCOPE Europe 2023
- Gustave Roussy Renews TrialMaster EDC Agreement with Anju
- IRTMaster by OmniComm: Accelerating Trial Development
- Joe Alea Appointed EVP of Product Development at Anju
- Pharma Company Enhances Med Affairs Communication with Anju
- PUBSTRAT MAX: Anju’s Innovative Publication Management
- PUBSTRAT’s 2019 Resurgence: Innovation & Service-Driven
- Steve Rosenberg Joins Anju’s Board of Directors
- TrialMaster 5.1: Anju Redefines Clinical Study Build Times
- Update on the Apache Log4j Security Vulnerability
- Vita Global Sciences Announces Strategic Partnership with Anju Software
Product Collateral
Publication Planning
- 17th Annual Meeting of ISMPP 2021
- 2019 European Meeting of ISMPP
- 2020 European Meeting of ISMPP: Achieving Clarity, Reach and Value
- Anju Leads Virtual Medical Content Compliance at TIPPA
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- CBI Medical Publications & Communications Forum – Anju
- Come visit us at the TIPPA Conference in San Diego
- How Big Data and AI Are Changing the Role of Medical Affairs
- INSIGHTS from ISMPP EU
- ISMPP EU Virtual Conference 2021
- ISMPP West 2019: Changing Tides in Scientific Communications
- ISMPP West 2021: Opportunities for Connectivity
- Join ISMPP in Sunny San Diego for Historic Meeting
- Laurence Birch Interview: Adaptive Life Sciences Tech
- MAPS Annual Meeting 2019 – Not just a one-time event…
- Meet Us at 15th Annual ISMPP Meeting, National Harbor
Publication Planning
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- Best Practices of Medical Affairs Publication Planning in 2021
- CBI’s Medical Publications Forum Insights
- Clinical Trial & Therapy Results: Anju’s Pubstrat MAX
- INSIGHTS from ISMPP EU
- Laurence Birch Interview: Adaptive Life Sciences Tech
- Publicizing Research: Reach Audiences and Combat Misinformation
- Researchers Whose Work May Lead to Cancer Treatment Breakthroughs
- Uncovering Predatory Journals and Conferences: Best Practices
- Why Medical Affairs Must Lead a Patient-Centric Approach to R&D
Publication Planning
Publication Planning
- Anju Acquires Sylogent for Publication Planning
- Anju Elevates Agency Support with PUBSTRAT Software Suite
- Anju Software Unveils Strategies for Data-Driven Decision-Making in Clinical Research at SCOPE Orlando 2024
- Anju Software Welcomes Natera to Its PUBSTRAT Partner Community
- Anju to Showcase Industry-Leading Publication Planning Solution at ISMPP Europe 2024
- Anju’s ECM Tested for Global Scalability
- INSIGHTS from ISMPP EU
- Laurence Birch Interview: Adaptive Life Sciences Tech
- PUBSTRAT MAX: Anju’s Innovative Publication Management
- PUBSTRAT’s 2019 Resurgence: Innovation & Service-Driven
RTSM
RTSM
RTSM
Site Identification
- Anju Expands Clinical Research Data Site & Investigator Optimization Offering
- Anju to Exhibit and Present at EUCROF24: Leveraging Data for Enhanced Site Selection and Feasibility in Clinical Trials
- How Trial Managers Can Increase Diversity in Clinical Trials
- Informed Site Selection is Mission Critical in Post COVID-19 Era
- Laurence Birch Interview: Adaptive Life Sciences Tech
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
- Using AI to Formulate Clinical Trial Research Questions
Site Identification
- How Trial Managers Can Increase Diversity in Clinical Trials
- Informed Site Selection is Mission Critical in Post COVID-19 Era
- Laurence Birch Interview: Adaptive Life Sciences Tech
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
- Using AI to Formulate Clinical Trial Research Questions
TA Scan
- 3 Tips to Perform a Disease Landscaping Analysis
- Anju Expands ta-Scan Offering
- Anju’s TA Scan Analysis of COVID-19 Update
- Anju’s TA Scan Selected by Leading Pharma Company to Enhance Clinical Research
- Building Opinion Leader Relationships in a Post-Pandemic World
- Chronic Obstructive Pulmonary Disease: Latest Clinical Data
- Community Pharmacies and Clinical Trial Enrollment
- Do You Have a Selection Strategy for Your Clinical Trial Endpoints?
- Global Diversity Data with TA Scan at SCOPE Europe 2023
- Insights into the 2023 ASCO Annual Meeting
- Laurence Birch Interview: Adaptive Life Sciences Tech
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
TA Scan
- 3 Tips to Perform a Disease Landscaping Analysis
- Anju’s TA Scan Analysis of COVID-19 Update
- Anju’s TA Scan Selected by Leading Pharma Company to Enhance Clinical Research
- Building Opinion Leader Relationships in a Post-Pandemic World
- Chronic Obstructive Pulmonary Disease: Latest Clinical Data
- Community Pharmacies and Clinical Trial Enrollment
- Do You Have a Selection Strategy for Your Clinical Trial Endpoints?
- Insights into the 2023 ASCO Annual Meeting
- Laurence Birch Interview: Adaptive Life Sciences Tech
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
TA Scan
- 3 Tips to Perform a Disease Landscaping Analysis
- Anju’s TA Scan Analysis of COVID-19 Update
- Anju’s TA Scan Selected by Leading Pharma Company to Enhance Clinical Research
- Building Opinion Leader Relationships in a Post-Pandemic World
- Can’t Miss Sessions at ACDM22
- Chronic Obstructive Pulmonary Disease: Latest Clinical Data
- Community Pharmacies and Clinical Trial Enrollment
- Do You Have a Selection Strategy for Your Clinical Trial Endpoints?
- Insights into the 2023 ASCO Annual Meeting
- Laurence Birch Interview: Adaptive Life Sciences Tech
- SCOPE Europe 2022: Don’t Miss These Events
- TA Scan Trial Planning Use Case
- TA Scan Won SCOPE Best of Show Award
- TA Scan’s Diversity Module Won Best of Show Award at SCOPE Europe 2023
Uncategorized
- Collaboration Opportunities Between Regulators and Medical Affairs
- Configurability and Customization: Key Features in an eTMF Solution
- How GDPR and Other Privacy Laws Impact Clinical Trial Data
- Improve Clinical Trial Management With Automated eTMS Tools
- Insights from ISMPP WEST 2019
- SCOPE 2023 Conference Preview
- Sized Up: Why Choosing the Right Trial Site Matters
- The FDA Race and Ethnicity Diversity Plan: How It Affects Clinical Trials
- Tracking Relationships: Understanding KPIs That Measure KOL Engagement
- Understanding Security and Role-Based Access in an eTMF Platform
- Using AI to Formulate Clinical Trial Research Questions
- Why CRO Staff Need Robust Digital Literacy Skills